Kimberly-Clark (KMB) 10-K 14 Feb 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information Document (USD $)	12 Months Ended
	Dec. 31, 2013	Feb. 07, 2014	Jun. 30, 2013
Entity Information [Line Items]	'	'	'
Entity Registrant Name	'KIMBERLY CLARK CORP	'	'
Entity Central Index Key	'0000055785	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Filer Category	'Large Accelerated Filer	'	'
Document Type	'10-K	'	'
Document Period End Date	31-Dec-13	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'
Amendment Flag	'false	'	'
Entity Common Stock, Shares Outstanding	'	379,402,894	'
Entity Well-known Seasoned Issuer	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Public Float	'	'	$37,200,000,000

Consolidated_Income_Statement

Consolidated Income Statement (USD $)	12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Income Statement [Abstract]	'		'		'
Net Sales	$21,152	[1]	$21,063	[1]	$20,846	[1]
Cost of products sold	13,912		14,314		14,694
Gross Profit	7,240		6,749		6,152
Marketing, research and general expenses	4,028		4,069		3,761
Other (income) and expense, net	4		-6		-51
Operating Profit	3,208		2,686		2,442
Interest income	20		18		18
Interest expense	-283		-284		-277
Income Before Income Taxes and Equity Interests	2,945		2,420		2,183
Provision for income taxes	-929		-768		-660
Income Before Equity Interests	2,016		1,652		1,523
Share of net income of equity companies	205		176		161
Net Income	2,221		1,828		1,684
Net income attributable to noncontrolling interests	-79		-78		-93
Net Income Attributable to Kimberly-Clark Corporation	$2,142		$1,750		$1,591
Per Share Basis	'		'		'
Basic	$5.58		$4.45		$4.02
Diluted	$5.53		$4.42		$3.99
Cash Dividends Declared	$3.24		$2.96		$2.80
[1]	Net sales in the United States to third parties totaled $9,783, $9,720 and $9,715 in 2013, 2012 and 2011, respectively.

Consolidated_Statement_of_Comp

Consolidated Statement of Comprehensive Income (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Statement of Other Comprehensive Income [Abstract]	'	'	'
Net income	$2,221	$1,828	$1,684
Other Comprehensive Income, Net of Tax:	'	'	'
Unrealized currency translation adjustments	-494	215	-249
Employee postretirement benefits	302	-377	-134
Other	17	-16	-30
Total Other Comprehensive Income (Loss), Net of Tax	-175	-178	-413
Comprehensive Income	2,046	1,650	1,271
Comprehensive income attributable to noncontrolling interests	-87	-93	-80
Comprehensive Income Attributable to Kimberly-Clark Corporation	$1,959	$1,557	$1,191

Consolidated_Balance_Sheet

Consolidated Balance Sheet (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Current Assets	'	'
Cash and cash equivalents	$1,054	$1,106
Accounts receivable, net	2,545	2,642
Inventories	2,233	2,348
Other current assets	718	493
Total Current Assets	6,550	6,589
Property, Plant and Equipment, Net	7,948	8,095
Investments in Equity Companies	382	355
Goodwill	3,181	3,337
Other Intangible Assets	243	246
Long-Term Note Receivable	0	395
Other Assets	615	856
TOTAL ASSETS	18,919	19,873
Current Liabilities	'	'
Debt payable within one year	375	1,115
Redeemable Preferred Securities of Subsidiaries	506	0
Trade accounts payable	2,598	2,443
Accrued expenses	2,060	2,244
Dividends payable	309	289
Total Current Liabilities	5,848	6,091
Long-Term Debt	5,386	5,070
Noncurrent Employee Benefits	1,312	1,992
Deferred Income Taxes	817	488
Other Liabilities	344	396
Redeemable Preferred and Common Securities of Subsidiaries	72	549
Stockholders' Equity	'	'
Preferred stock—no par value—authorized 20.0 million shares, none issued	0	0
Common stock—$1.25 par value—authorized 1.2 billion shares; issued 428.6 million shares at December 31, 2013 and 2012	536	536
Additional paid-in capital	594	481
Common stock held in treasury, at cost—47.8 million and 39.3 million shares at December 31, 2013 and 2012	-3,746	-2,796
Retained earnings	9,714	8,823
Accumulated other comprehensive income (loss)	-2,242	-2,059
Total Kimberly-Clark Corporation Stockholders' Equity	4,856	4,985
Noncontrolling Interests	284	302
Total Stockholders' Equity	5,140	5,287
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$18,919	$19,873

Consolidated_Balance_Sheet_Con

Consolidated Balance Sheet Consolidated Balance Sheet (Parenthetical) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Statement of Financial Position [Abstract]	'	'
Preferred stock, Value, Issued	$0	$0
Preferred stock, shares authorized	20,000,000	20,000,000
Preferred stock, shares issued	0	0
Common stock, par value	$1.25	$1.25
Common stock, shares authorized	1,200,000,000	1,200,000,000
Common stock, shares Issued	428,600,000	428,600,000
Common stock held in treasury, shares	47,798,000	39,322,000

Consolidated_Statement_of_Stoc

Consolidated Statement of Stockholders' Equity (USD $)	Total	Common Stock Issued [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Noncontrolling Interests [Member]
In Millions, except Share data in Thousands, unless otherwise specified
Beginning Balance at Dec. 31, 2010	'	$598	$425	($4,726)	$11,086	($1,466)	$285
Beginning Balance (in shares) at Dec. 31, 2010	'	478,597	'	'	'	'	'
Treasury Stock, Shares	32,937	'	'	'	'	'	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'	'	'	'	'	'
Net income in stockholders' equity	1,684	'	'	'	1,591	'	'
Net income in stockholders' equity	'	'	'	'	'	'	39
Other comprehensive income, net of tax	'	'	'	'	'	'	'
Unrealized translation	-249	'	'	'	'	-236	-13
Employee postretirement benefits	134	'	'	'	'	-133	-1
Other	-30	'	'	'	'	-31	1
Stock-based awards exercised or vested	'	'	-47	490	'	'	'
Stock-based awards exercised or vested (in shares)	'	'	'	-7,924	'	'	'
Income tax benefits on stock-based compensation	'	'	10	'	'	'	'
Shares repurchased (in shares)	'	'	'	19,120	'	'	'
Shares repurchased	'	'	'	-1,247	'	'	'
Shares retired (in shares)	'	-50,000	'	-50,000	'	'	'
Shares retired	'	-62	'	3,378	-3,316	'	'
Recognition of stock-based compensation	48	'	48	'	'	'	'
Dividends declared	'	'	'	'	-1,107	'	'
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders	'	'	'	'	'	'	29
Other	'	'	4	0	-10	'	-2
Ending Balance at Dec. 31, 2011	'	536	440	-2,105	8,244	-1,866	280
Ending Balance (in shares) at Dec. 31, 2011	'	428,597	'	'	'	'	'
Treasury Stock, Shares	39,322	'	'	'	'	'	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'	'	'	'	'	'
Net income in stockholders' equity	1,828	'	'	'	1,750	'	'
Net income in stockholders' equity	'	'	'	'	'	'	47
Other comprehensive income, net of tax	'	'	'	'	'	'	'
Unrealized translation	215	'	'	'	'	195	20
Employee postretirement benefits	377	'	'	'	'	-372	-5
Other	-16	'	'	'	'	-16	0
Stock-based awards exercised or vested	'	'	-78	643	'	'	'
Stock-based awards exercised or vested (in shares)	'	'	'	-10,492	'	'	'
Income tax benefits on stock-based compensation	'	'	43	'	'	'	'
Shares repurchased (in shares)	'	'	'	16,877	'	'	'
Shares repurchased	'	'	'	-1,333	'	'	'
Recognition of stock-based compensation	67	'	67	'	'	'	'
Dividends declared	'	'	'	'	-1,163	'	'
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders	'	'	'	'	'	'	38
Other	'	'	9	-1	-8	'	-2
Ending Balance at Dec. 31, 2012	5,287	536	481	-2,796	8,823	-2,059	302
Ending Balance (in shares) at Dec. 31, 2012	'	428,597	'	'	'	'	'
Treasury Stock, Shares	47,798	'	'	'	'	'	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'	'	'	'	'	'
Net income in stockholders' equity	2,221	'	'	'	2,142	'	'
Net income in stockholders' equity	'	'	'	'	'	'	48
Other comprehensive income, net of tax	'	'	'	'	'	'	'
Unrealized translation	-494	'	'	'	'	-499	5
Employee postretirement benefits	-302	'	'	'	'	298	4
Other	17	'	'	'	'	18	-1
Stock-based awards exercised or vested	'	'	-33	264	'	'	'
Stock-based awards exercised or vested (in shares)	'	'	'	-4,108	'	'	'
Income tax benefits on stock-based compensation	'	'	46	'	'	'	'
Shares repurchased (in shares)	'	'	'	12,584	'	'	'
Shares repurchased	'	'	'	-1,214	'	'	'
Recognition of stock-based compensation	92	'	92	'	'	'	'
Dividends declared	'	'	'	'	-1,244	'	'
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders	'	'	'	'	'	'	39
Other	'	'	8	0	-7	'	-35
Ending Balance at Dec. 31, 2013	$5,140	$536	$594	($3,746)	$9,714	($2,242)	$284
Ending Balance (in shares) at Dec. 31, 2013	'	428,597	'	'	'	'	'

Consolidated_Cash_Flow_Stateme

Consolidated Cash Flow Statement (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Operating Activities	'	'	'
Net income	$2,221	$1,828	$1,684
Depreciation and amortization	863	857	1,091
Asset impairments	45	171	58
Recognition of stock-based compensation	92	67	48
Deferred income taxes	151	224	274
Net (gains) losses on asset dispositions	11	35	-6
Equity companies' earnings in excess of dividends paid	-36	-27	-23
(Increase) decrease in operating working capital	-158	119	-262
Postretirement benefits	-158	7	-574
Other	9	7	-2
Cash Provided by Operations	3,040	3,288	2,288
Investing Activities	'	'	'
Capital spending	-953	-1,093	-968
Acquisitions of businesses	-32	-5	0
Proceeds from dispositions of property	129	9	51
Proceeds from sales of investments	26	23	28
Investments in time deposits	-93	-212	-158
Maturities of time deposits	94	95	141
Proceeds from maturity of note receivable	0	0	220
Other	-15	-1	5
Cash Used for Investing	-844	-1,184	-681
Financing Activities	'	'	'
Cash dividends paid	-1,223	-1,151	-1,099
Change in short-term borrowings	-287	271	13
Debt proceeds	890	315	839
Debt repayments	-544	-492	-107
Redemption of redeemable preferred securities of subsidiary	0	0	-500
Cash paid on redeemable preferred securities of subsidiary	-27	-28	-57
Proceeds from exercise of stock options	232	565	435
Acquisitions of common stock for the treasury	-1,216	-1,284	-1,246
Other	-10	2	-19
Cash Used for Financing	-2,185	-1,802	-1,741
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-63	40	22
Increase (Decrease) in Cash and Cash Equivalents	-52	342	-112
Cash and Cash Equivalents - Beginning of Year	1,106	764	876
Cash and Cash Equivalents - End of Year	$1,054	$1,106	$764

Accounting_Policies

Accounting Policies	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Accounting Policies	'
	Accounting Policies
	Basis of Presentation
	The Consolidated Financial Statements present the accounts of Kimberly-Clark Corporation and all subsidiaries in which it has a controlling financial interest as if they were a single economic entity in conformity with accounting principles generally accepted in the United States of America ("GAAP"). All intercompany transactions and accounts are eliminated in consolidation. The terms "Corporation," "Kimberly-Clark," "we," "our," and "us" refer to Kimberly-Clark Corporation and all subsidiaries in which it has a controlling financial interest. Dollar amounts are reported in millions, except per share dollar amounts, unless otherwise noted.
	Use of Estimates
	The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting periods. Actual results could differ from these estimates, and changes in these estimates are recorded when known. Estimates are used in accounting for, among other things, consumer and trade promotion and rebate accruals, pension and other postretirement benefits, future cash flows associated with impairment testing for goodwill and long-lived assets, and deferred tax assets and potential income tax assessments.
	Cash Equivalents
	Cash equivalents are short-term investments with an original maturity date of three months or less.
	Inventories and Distribution Costs
	Most U.S. inventories are valued at the lower of cost, using the Last-In, First-Out (LIFO) method, or market. The balance of the U.S. inventories and inventories of consolidated operations outside the U.S. are valued at the lower of cost, using either the First-In, First-Out (FIFO) or weighted-average cost methods, or market. Distribution costs are classified as cost of products sold.
	Property and Depreciation
	Property, plant and equipment are stated at cost and are depreciated on the straight-line method. Buildings are depreciated over their estimated useful lives, primarily 40 years. Machinery and equipment are depreciated over their estimated useful lives, primarily ranging from 16 to 20 years. Purchases of computer software, including external costs and certain internal costs (including payroll and payroll-related costs of employees) directly associated with developing significant computer software applications for internal use, are capitalized. Computer software costs are amortized on the straight-line method over the estimated useful life of the software, which generally does not exceed 5 years.
	Estimated useful lives are periodically reviewed and, when warranted, changes are made to them. Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. An impairment loss would be indicated when estimated undiscounted future cash flows from the use and eventual disposition of an asset group, which are identifiable and largely independent of the cash flows of other asset groups, are less than the carrying amount of the asset group. Measurement of an impairment loss would be based on the excess of the carrying amount of the asset group over its fair value. Fair value is measured using discounted cash flows or independent appraisals, as appropriate. When property is sold or retired, the cost of the property and the related accumulated depreciation are removed from the Consolidated Balance Sheet and any gain or loss on the transaction is included in income.
	Goodwill and Other Intangible Assets
	Goodwill represents costs in excess of fair values assigned to the underlying net assets of acquired businesses. Goodwill is not amortized, but rather is tested for impairment annually and whenever events and circumstances indicate that impairment may have occurred. During the third quarter of 2013, we changed the measurement date for our annual goodwill impairment test from the beginning of the fourth quarter to the beginning of the third quarter. This change did not result in the delay, acceleration or avoidance of an impairment charge. We believe this timing is preferable as it better aligns the goodwill impairment test with our strategic business planning process, which is a key component of the goodwill impairment test. The change was applied prospectively, as retrospective application would have been impractical because we are unable to objectively select assumptions that would have been used in previous periods without the benefit of hindsight.
	Impairment testing compares the reporting unit carrying amount of goodwill with its fair value. Fair value is estimated based on discounted cash flows. If the reporting unit carrying amount of goodwill exceeds its fair value, an impairment charge would be recorded. We have completed the required annual testing of goodwill for impairment for all reporting units and have determined that goodwill is not impaired.
	Intangible assets with finite lives are amortized over their estimated useful lives and are reviewed for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. Estimated useful lives range from 2 to 30 years for trademarks, 5 to 17 years for patents and developed technologies, and 5 to 16 years for other intangible assets. An impairment loss would be indicated when estimated undiscounted future cash flows from the use of the asset are less than its carrying amount. An impairment loss would be measured as the difference between the fair value (based on discounted future cash flows) and the carrying amount of the asset.
	Investments in Equity Companies
	Investments in companies which we do not control but over which we have the ability to exercise significant influence and that, in general, are at least 20 percent-owned by us, are stated at cost plus equity in undistributed net income. These investments are evaluated for impairment when warranted. An impairment loss would be recorded whenever a decline in value of an equity investment below its carrying amount is determined to be other than temporary. In judging "other than temporary," we would consider the length of time and extent to which the fair value of the equity company investment has been less than the carrying amount, the near-term and longer-term operating and financial prospects of the equity company, and our longer-term intent of retaining the investment in the equity company.
	Revenue Recognition
	Sales revenue is recognized at the time of product shipment or delivery, depending on when title passes, to unaffiliated customers, and when all of the following have occurred: a firm sales agreement is in place, pricing is fixed or determinable, and collection is reasonably assured. Sales are reported net of returns, consumer and trade promotions, rebates and freight allowed. Taxes imposed by governmental authorities on our revenue-producing activities with customers, such as sales taxes and value-added taxes, are excluded from net sales.
	Sales Incentives and Trade Promotion Allowances
	The cost of promotion activities provided to customers is classified as a reduction in sales revenue. In addition, the estimated redemption value of consumer coupons is recorded at the time the coupons are issued and classified as a reduction in sales revenue. Estimates of trade promotion liabilities for promotional program costs incurred, but unpaid, are generally based on estimates of the quantity of customer sales, timing of promotional activities and forecasted costs for activities within the promotional programs.
	Advertising Expense
	Advertising costs are expensed in the year the related advertisement or campaign is first presented by the media. For interim reporting purposes, advertising expenses are charged to operations as a percentage of sales based on estimated sales and related advertising expense for the full year.
	Research Expense
	Research and development costs are charged to expense as incurred.
	Environmental Expenditures
	Environmental expenditures related to current operations that qualify as property, plant and equipment or which substantially increase the economic value or extend the useful life of an asset are capitalized, and all other environmental expenditures are expensed as incurred. Liabilities are recorded when environmental assessments and/or remedial efforts are probable and the costs can be reasonably estimated. Generally, the timing of these accruals coincides with completion of a feasibility study or a commitment to a formal plan of action. Liabilities for future expenditures for environmental remediation obligations are not discounted and do not reflect any anticipated recoveries from insurers.
	Foreign Currency Translation
	The income statements of foreign operations, other than those in highly inflationary economies, are translated into U.S. dollars at rates of exchange in effect each month. The balance sheets of these operations are translated at period-end exchange rates, and the differences from historical exchange rates are reflected in stockholders' equity as unrealized translation adjustments.
	The income statements and balance sheets of operations in highly inflationary economies are translated into U.S. dollars using both current and historical rates of exchange. We account for our operations in Venezuela using highly inflationary accounting. On February 13, 2013, the Venezuelan government announced a devaluation of the Central Bank of Venezuela ("Central Bank") regulated currency exchange system rate to 6.3 bolivars per U.S. dollar and the elimination of the SITME rate. As a result of the devaluation, we recorded a $26 after tax charge ($36 pre-tax) related to the remeasurement of the local currency-denominated balance sheet to the new exchange rate in 2013. Prior to this devaluation, we used the Central Bank SITME rate of 5.4 bolivars per U.S. dollar to measure K-C Venezuela's bolivar-denominated transactions into U.S. dollars. The $36 pre-tax charge is reflected in the Consolidated Income Statement in other (income) and expense, net for the year ended December 31, 2013. In the Consolidated Cash Flow Statement, this non-cash charge is included in other in cash provided by operations.
	At December 31, 2013, K-C Venezuela had a bolivar-denominated net monetary asset position of $309 and our net investment in K-C Venezuela was $445, both valued at 6.3 bolivars per U.S. dollar. Net sales of K-C Venezuela represented approximately 2 percent of consolidated net sales for the years ended December 31, 2013 and 2012 and approximately 1 percent of consolidated net sales for the year ended December 31, 2011.
	Derivative Instruments and Hedging
	All derivative instruments are recorded as assets or liabilities on the balance sheet at fair value. Changes in the fair value of derivatives are either recorded in the income statement or other comprehensive income, as appropriate. The gain or loss on derivatives designated as fair value hedges and the offsetting loss or gain on the hedged item attributable to the hedged risk are included in income in the period that changes in fair value occur. The effective portion of the gain or loss on derivatives designated as cash flow hedges is included in other comprehensive income in the period that changes in fair value occur, and is reclassified to income in the same period that the hedged item affects income. The gain or loss on derivatives designated as hedges of investments in foreign subsidiaries is recognized in other comprehensive income to offset the change in value of the net investments being hedged. Any ineffective portion of cash flow hedges and net investment hedges is immediately recognized in income. Certain foreign-currency derivative instruments not designated as hedging instruments have been entered into to manage a portion of our foreign currency transactional exposures. The gain or loss on these derivatives is included in income in the period that changes in their fair values occur. Our policies allow the use of derivatives for risk management purposes and prohibit their use for speculation. Our policies also prohibit the use of any leveraged derivative instrument. Consistent with our policies, foreign currency derivative instruments, interest rate swaps and locks, and the majority of commodity hedging contracts are entered into with major financial institutions. At inception we formally designate certain derivatives as cash flow, fair value or net investment hedges and establish how the effectiveness of these hedges will be assessed and measured. This process links the derivatives to the transactions or financial balances they are hedging. Changes in the fair value of derivatives not designated as hedging instruments are recorded in earnings as they occur. See Note 14 for disclosures about derivative instruments and hedging activities.
	New Accounting Standards
	In February 2013, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income ("AOCI"), an amendment to FASB Accounting Standards Codification Topic 220, Comprehensive Income. This update requires disclosure of amounts reclassified out of AOCI by component. In addition, an entity is required to present either on the face of the statement of operations or in the notes, significant amounts reclassified out of AOCI by the respective line items of net income but only if the amount reclassified is required to be reclassified to net income in its entirety in the same reporting period. For amounts not reclassified to net income in their entirety, an entity is required to cross-reference to other disclosures that provide additional detail about those amounts. We adopted ASU No. 2013-02 on January 1, 2013.

Proposed_Spinoff_of_Health_Car

Proposed Spinoff of Health Care Business Proposed Spinoff of Health Care Business (Health Care Spin-off [Member])	12 Months Ended
	Dec. 31, 2013
Health Care Spin-off [Member]	'
Restructuring Cost and Reserve	'
Restructuring and Related Activities Disclosure	'
	Proposed Spin-Off of Health Care Business
	In November 2013, we announced that our Board of Directors authorized management to pursue a potential tax-free spin-off of our health care business. A spin-off would create a stand-alone, publicly traded health care company with approximately $1.6 billion in annual net sales, focused on the sale of surgical and infection prevention products for the operating room and other medical supplies, and medical devices focused on pain management, respiratory and digestive health.
	Although our current target is to complete the spin-off by the end of the third quarter of 2014, there are no assurances as to when the proposed spin-off will be completed, if at all, or if the spin-off will be completed based on the expected plans.

European_Strategic_Changes

European Strategic Changes (European Strategic Changes [Member])	12 Months Ended
	Dec. 31, 2013
European Strategic Changes [Member]	'
Restructuring Cost and Reserve	'
European Strategic Changes	'
	European Strategic Changes
	In 2012, we approved strategic changes related to our Western and Central European consumer and professional businesses to focus our resources and investments on stronger market positions and growth opportunities. We have exited the diaper category in that region, with the exception of the Italian market, and divested or exited some lower-margin businesses, mostly in consumer tissue, in certain markets. The changes primarily affect our consumer businesses, with a modest impact on K-C Professional ("KCP"). The restructuring actions commenced in 2012 and are expected to be completed by December 31, 2014.
	Restructuring actions related to the strategic changes involve the sale or closure of five of our European manufacturing facilities and streamlining our administrative organization. The following charges were incurred in connection with the European strategic changes:
		Year Ended December 31
		2013				2012
	Asset impairments	$	22			$	147
	Charges for workforce reductions	10				77
	Asset write-offs	13				10
	Incremental depreciation	18				8
	Benefit from pension curtailment	(31		)		—
	Other exit costs	22				8
	Cost of products sold	54				250
	Charges for workforce reductions and other exit costs included in marketing, research and general expenses and other (income) and expense, net	27				49
	Provision for income taxes	(15		)		(57		)
	Net charges	$	66			$	242
	The measurement of the charge for asset impairments was based on the excess of the carrying value of the impacted asset groups over their fair values.  These fair values were measured using discounted cash flows, expected over the limited time the assets would remain in use, and as a result, the assets were essentially written off. The use of the discounted cash flows represents a level 3 measure under the fair value hierarchy.
	See Note 17 for charges related to the European strategic changes by segment.
	The following summarizes the cash charges recorded and reconciles these charges to accrued expenses:
			2013				2012
	Accrued expenses - January 1		$	133			$	—
	Charges for workforce reductions and other exit costs		69				134
	Cash payments		(156		)		(4		)
	Currency and other		(9		)		3
	Accrued expenses - December 31		$	37			$	133

Pulp_And_Tissue_Restructuring

Pulp And Tissue Restructuring (Pulp And Tissue Restructuring [Member])	12 Months Ended
	Dec. 31, 2013
Pulp And Tissue Restructuring [Member]	'
Restructuring Cost and Reserve	'
Restructuring and Related Activities Disclosure	'
	Pulp and Tissue Restructuring Actions
	In 2011 and 2012, we executed pulp and tissue restructuring actions in order to exit our remaining integrated pulp manufacturing operations and improve the underlying profitability and return on invested capital of our consumer tissue and KCP businesses. These actions involved the streamlining, sale or closure of seven of our manufacturing facilities around the world. In conjunction with these actions, we exited certain non-strategic products, primarily non-branded offerings, and transferred some production to lower-cost facilities in order to improve overall profitability and returns. The actions were substantially complete at December 31, 2012.
	During 2012, charges of $128, $6 and $1 were recorded in cost of products sold, marketing, research and general expenses and other (income) and expense, net, respectively, for the restructuring actions. A related benefit of $49 was recorded in provision for income taxes. On a geographic basis, charges of $97, $35 and $3 were recorded in the United States, Australia and elsewhere, respectively.
	During 2011, charges of $407, $6 and $2 were recorded in cost of products sold, marketing, research and general expenses and other (income) and expense, net, respectively, for the restructuring actions. A related benefit of $126 was recorded in provision for income taxes. On a geographic basis, charges of $204, $133 and $78 were recorded in the United States, Australia and elsewhere, respectively.
	See Note 17 for charges by segment.

Fair_Value_Information

Fair Value Information	12 Months Ended
	Dec. 31, 2013
Fair Value Disclosures [Abstract]	'
Fair Value Information	'
	Fair Value Information
	The following fair value information is based on a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The three levels in the hierarchy used to measure fair value are:
	Level 1—Unadjusted quoted prices in active markets accessible at the reporting date for identical assets and liabilities.
	Level 2—Quoted prices for similar assets or liabilities in active markets. Quoted prices for identical or similar assets and liabilities in markets that are not considered active or financial instruments for which all significant inputs are observable, either directly or indirectly.
	Level 3—Prices or valuations that require inputs that are significant to the valuation and are unobservable.
	A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.
	During 2013 and 2012, there were no significant transfers among level 1, 2 or 3 fair value determinations.
	Set forth below are the assets and liabilities that are measured on a recurring basis at fair value and the inputs used to develop those fair value measurements.
		31-Dec-13				Fair Value Measurements
						Level 1				Level 2				Level 3
	Assets
	Company-owned life insurance ("COLI")	$	55			$	—			$	55			$	—
	Available-for-sale securities	22				22				—				—
	Derivatives	62				—				62				—
	Total	$	139			$	22			$	117			$	—
	Liabilities
	Derivatives	$	49			$	—			$	49			$	—
		31-Dec-12				Fair Value Measurements
						Level 1				Level 2				Level 3
	Assets
	COLI	$	49			$	—			$	49			$	—
	Available-for-sale securities	17				17				—				—
	Derivatives	61				—				61				—
	Total	$	127			$	17			$	110			$	—
	Liabilities
	Derivatives	$	63			$	—			$	63			$	—
	The COLI policies are a source of funding primarily for our nonqualified employee benefits and are included in other assets. Available-for-sale securities are included in other assets. See Note 14 for information on the classification of derivatives in the Consolidated Balance Sheet.
	Level 1 Fair Values—The fair values of certain available-for-sale securities are based on quoted market prices in active markets for identical assets.
	Level 2 Fair Values—The fair value of the COLI policies is derived from investments in a mix of money market, fixed income and equity funds managed by unrelated fund managers. The fair values of derivatives used to manage interest rate risk and commodity price risk are based on LIBOR rates and interest rate swap curves and NYMEX price quotations, respectively. The fair value of hedging instruments used to manage foreign currency risk is based on published quotations of spot currency rates and forward points, which are converted into implied forward currency rates. Additional information on our use of derivative instruments is contained in Note 14.
	The following table includes the fair value of our financial instruments for which disclosure of fair value is required:
		Fair Value		Carrying				Estimated				Carrying				Estimated
		Hierarchy		Amount				Fair				Amount				Fair
		Level						Value								Value
				December 31, 2013								December 31, 2012
	Assets
	Cash and cash equivalents(a)	1		$	1,054			$	1,054			$	1,106			$	1,106
	Time deposits(b)	1		222				222				224				224
	Note receivable(c)	3		16				16				395				392
	Liabilities and redeemable securities of subsidiaries
	Short-term debt(d)	2		63				63				359				359
	Monetization loan(c)	3		—				—				397				400
	Long-term debt(e)	2		5,698				6,271				5,429				6,527
	Redeemable preferred securities of subsidiaries(c)	3		532				552				506				543
	Redeemable common securities of subsidiary(f)	3		46				46				43				43
	(a)	Cash equivalents are composed of certificates of deposit, time deposits and other interest-bearing investments with original maturity dates of 90 days or less. Cash equivalents are recorded at cost, which approximates fair value.
	(b)	Time deposits are comprised of deposits with original maturities of more than 90 days but less than one year and instruments with original maturities of greater than one year, included in other current assets or other assets in the Consolidated Balance Sheet, as appropriate. Time deposits are recorded at cost, which approximates fair value.
	(c)	The note, monetization loan and redeemable preferred securities of subsidiaries are not traded in active markets. Accordingly, their fair values were calculated using a floating rate pricing model that compared the stated spread to the fair value spread to determine the price at which each of the financial instruments should trade. The model used the following inputs to calculate fair values: face value, current LIBOR rate, unobservable fair value credit spread, stated spread, maturity date and interest or dividend payment dates. See Note 8 for additional information.
	(d)	Short-term debt is comprised of U.S. commercial paper and/or other similar short-term debt issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value.
	(e)	Long-term debt includes the current portion of these debt instruments and excludes the monetization loan. Fair values were estimated based on quoted prices for financial instruments for which all significant inputs were observable, either directly or indirectly.
	(f)	The fair value of the redeemable common securities of subsidiary was based on various inputs, including an independent third-party appraisal, adjusted for current market conditions.

Acquisitions_and_Intangible_As

Acquisitions and Intangible Assets	12 Months Ended
	Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'
Acquisitions and Intangible Assets	'
	Acquisitions and Intangible Assets
	The changes in the carrying amount of goodwill by business segment are as follows:
		Personal			Consumer			K-C			Health			Total
		Care			Tissue			Professional			Care
	Balance at December 31, 2011	$	769		$	694		$	443		$	1,434		$	3,340
	Currency and other	(5		)	1			(1		)	2			(3		)
	Balance at December 31, 2012	764			695			442			1,436			3,337
	Acquisitions	6			—			—			3			9
	Currency and other	(86		)	(54		)	(18		)	(7		)	(165		)
	Balance at December 31, 2013	$	684		$	641		$	424		$	1,432		$	3,181
	At December 31, 2013 and 2012, we had intangible assets with indefinite useful lives of $7 and $11, respectively, related to acquired in-process research and development. Intangible assets subject to amortization consist of the following at December 31:
		2013						2012
		Gross			Accumulated			Gross			Accumulated
		Carrying			Amortization			Carrying			Amortization
		Amount						Amount
	Trademarks	$	252		$	163		$	253		$	156
	Patents and developed technologies	201			85			158			64
	Other	93			62			105			61
	Total	$	546		$	310		$	516		$	281
	Amortization expense for intangible assets was $39 in 2013, $29 in 2012 and $24 in 2011. Amortization expense is estimated to be $42 in 2014, $34 in 2015, $28 in 2016, $23 in 2017 and $19 in 2018.

Debt

Debt	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Debt	'
	Debt
	Long-term debt is comprised of the following:
		Weighted-	Maturities	December 31
		Average
		Interest
		Rate		2013		2012
	Notes and debentures	5.20%	2014 - 2043	$	5,163	$	4,857
	Dealer remarketable securities	4.20%	2014 - 2016	200		200
	Industrial development revenue bonds	0.20%	2015 - 2034	261		261
	Bank loans and other financings in various currencies	5.60%	2014 - 2025	74		508
	Total long-term debt			5,698		5,826
	Less current portion			312		756
	Long-term portion			$	5,386	$	5,070
	Scheduled maturities of long-term debt for the next five years are $312 in 2014, $353 in 2015, $302 in 2016, $962 in 2017 and $902 in 2018.
	In May 2013, we issued $250 aggregate principal amount of floating rate notes due May 15, 2016, $350 aggregate principal amount of 2.4% notes due June 1, 2023, and $250 aggregate principal amount of 3.7% notes due June 1, 2043. Proceeds from the offering were used to repay our $500 aggregate principal amount of 5.0% notes due August 15, 2013, to fund investment in our business and for general corporate purposes.
	In 2012, we issued $300 aggregate principal amount of 2.4% notes due March 1, 2022.  Proceeds from the offering were used for general corporate purposes, including to repay a portion of our $400 aggregate principal amount of 5.625% notes that were due February 15, 2012.
	In 2011, we issued $250 aggregate principal amount of 3.875% notes due March 1, 2021 and $450 aggregate principal amount of 5.3% notes due March 1, 2041. Proceeds from the offering were used for general corporate purposes, including purchasing shares of company common stock pursuant to publicly announced share repurchase programs.
	In 2006, we issued $200 of dealer remarketable securities that have a final maturity in 2016. The remarketing provisions of these debt instruments require that each year the securities either be remarketed by the dealer or repaid. In both 2012 and 2013, the dealer exercised its option to remarket the securities for another year, and remarketed the securities to third parties.
	We maintain a $1.5 billion revolving credit facility, scheduled to expire in October 2016, as well as the option to increase this facility by an additional $500.  This facility, currently unused, supports our commercial paper program and would provide liquidity in the event our access to the commercial paper market is unavailable for any reason.

Redeemable_Preferred_and_Commo

Redeemable Preferred and Common Securities of Subsidiaries	12 Months Ended
	Dec. 31, 2013
Redeemable Preferred and Common Securities of Subsidiaries [Abstract]	'
Redeemable Preferred and Common Securities of Subsidiaries	'
	Redeemable Preferred and Common Securities of Subsidiaries
	Monetization Financing Entity
	Prior to December 2013, we had a minority voting interest in a financing entity used to monetize a note receivable received from the sale of nonstrategic timberlands and related assets to a nonaffiliated buyer. We were the primary beneficiary of the entity and, accordingly, consolidated the entity in our Consolidated Financial Statements. The note receivable has a face value of $397 and is backed by an irrevocable standby letter of credit issued by a money center bank. The note receivable matures on September 30, 2014 and earns interest at LIBOR plus 75 bps. The note receivable and other assets were transferred to the financing entity in 1999. A nonaffiliated financial institution made a substantive capital investment in the financing entity and had majority voting control over it. The nonaffiliated financial institution also made a monetization loan of $397 to us, which was assumed by the financing entity at the time the note receivable was transferred to the financing entity. The monetization loan was secured by the note receivable and intercompany financial instruments, which served as secondary collateral for the monetization loan. The monetization loan had a maturity date of January 31, 2014, and had an interest rate of LIBOR plus 150 bps.
	In December 2013, the financing entity was restructured and its assets were divided. The restructuring resulted in the financial institution acquiring ownership rights to most of the note receivable and assuming the monetization loan of $397. In addition, as part of the restructuring, the financial institution acquired $26 face value of redeemable preferred securities issued by one of our subsidiaries, recorded at their transfer-date fair value. Under the restructuring, we became the owners of any assets that were previously part of the financing entity that are not owned by the financial institution. Net cash payments to restructure the financing entity and divide its assets totaled $24 in 2013, which was included in other in cash used for financing in the Consolidated Cash Flow Statement.
	In addition, on July 7, 2011, we collected the face value of a note receivable of $220 in cash held by another financing entity in which we acquired the voting equity interest of the nonaffiliated financial institution and its monetization loan rights in November 2009.
	Luxembourg-Based Financing Subsidiary
	In February 2001, we, together with a non-affiliated third party entity (the "Third Party"), formed a Luxembourg-based financing subsidiary. We are the primary beneficiary of the subsidiary and, accordingly, consolidate the subsidiary in our Consolidated Financial Statements.
	Prior to December 2011, the Third Party had investments in two classes of voting-preferred securities issued by the subsidiary (the "Preferred Securities"). The two classes of Preferred Securities, Class A-1 and Class A-2, had a par value of $500 each for an aggregate of $1 billion. The Class A-1 and Class A-2 Preferred Securities accrue a fixed annual rate of return of 5.074 percent and 5.417 percent, respectively, which is paid on a quarterly basis. In December 2011, the subsidiary redeemed the Class A-1 Preferred Securities. The Class A-2 Preferred Securities are redeemable in December 2014. At December 31, 2013, the Preferred Securities represent 96 percent of the voting power of the subsidiary.
	In December 2013, the subsidiary elected to redeem the Class A-2 Preferred Securities in December 2014. As a result, the $500 redemption value of the Class A-2 Preferred Securities is included in current liabilities as of December 31, 2013 in our Consolidated Balance Sheet. The subsidiary also has issued voting-preferred and common securities to Kimberly-Clark for total cash proceeds of $500. These securities are entitled to a combined four percent vote, and the common securities are entitled to all of the residual equity after satisfaction of the preferred interests.
	Approximately 98 percent of the total cash contributed to the entity has been loaned to Kimberly-Clark. These long-term loans bear fixed annual interest rates. The funds remaining in the financing subsidiary are primarily invested in equity-based exchange-traded funds. The preferred and common securities of the subsidiary held by Kimberly-Clark and the intercompany loans have been eliminated in our Consolidated Financial Statements. The return on the Preferred Securities was $27, $27 and $52 in 2013, 2012 and 2011, respectively, which is included in net income attributable to noncontrolling interests in our Consolidated Income Statement.
	Neither the Third Party nor creditors of the subsidiary have recourse to our general credit. If our credit ratings are downgraded below BBB- or Baa3, then the loans become payable to the financing subsidiary to the extent necessary to enable the financing subsidiary to pay the redemption value. Our credit ratings are above this level as of February 14, 2014, and we do not anticipate they will be downgraded below this level prior to the redemption in December 2014.
	Common Securities of Subsidiary
	In addition, our subsidiary in Central America has outstanding redeemable common securities that are held by a noncontrolling interest.

StockBased_Compensation

Stock-Based Compensation	12 Months Ended
	Dec. 31, 2013
Share-based Compensation [Abstract]	'
Stock-Based Compensation	'
	Stock-Based Compensation
	We have a stock-based Equity Participation Plan and an Outside Directors' Compensation Plan (the "Plans"), under which we can grant stock options, restricted shares and restricted share units to employees and outside directors. As of December 31, 2013, the number of shares of common stock available for grants under the Plans aggregated 21.3 million shares.
	Stock options are granted at an exercise price equal to the fair market value of our common stock on the date of grant, and they have a term of 10 years. Stock options are subject to graded vesting whereby options vest 30 percent at the end of each of the first two 12-month periods following the grant and 40 percent at the end of the third 12-month period.
	Restricted shares, time-vested restricted share units and performance-based restricted share units granted to employees are valued at the closing market price of our common stock on the grant date and vest generally at the end of three years. The number of performance-based share units that ultimately vest ranges from zero to 200 percent of the number granted, based on performance tied to return on invested capital ("ROIC") and net sales during the three-year performance period. ROIC and net sales targets are set at the beginning of the performance period. Restricted share units granted to outside directors are valued at the closing market price of our common stock on the grant date and vest when they are granted. The restricted period begins on the date of grant and expires on the date the outside director retires from or otherwise terminates service on our Board.
	At the time stock options are exercised or restricted shares and restricted share units become payable, common stock is issued from our accumulated treasury shares. Dividend equivalents are credited on restricted share units on the same date and at the same rate as dividends are paid on Kimberly-Clark's common stock. These dividend equivalents, net of estimated forfeitures, are charged to retained earnings.
	Stock-based compensation costs of $92, $67 and $48 and related deferred income tax benefits of $35, $20 and $15 were recognized for 2013, 2012 and 2011, respectively.
	The fair value of stock option awards was determined using a Black-Scholes-Merton option-pricing model utilizing a range of assumptions related to dividend yield, volatility, risk-free interest rate, and employee exercise behavior. Dividend yield is based on historical experience and expected future dividend actions. Expected volatility is based on a blend of historical volatility and implied volatility from traded options on Kimberly-Clark's common stock. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant. We estimate forfeitures based on historical data.
	The weighted-average fair value of options granted was estimated at $7.15, $3.25 and $2.98, in 2013, 2012 and 2011, respectively, per option on the date of grant based on the following assumptions:
		Year Ended December 31
		2013		2012			2011
	Dividend yield	3.7	%	4.5	%		5	%
	Volatility	15.4	%	12.86	%		12.54	%
	Risk-free interest rate	0.87	%	1.08	%		2.26	%
	Expected life—years	5.1		5.8			6.3
	Total remaining unrecognized compensation costs and amortization period are as follows:
		December 31, 2013			Weighted-
					Average
					Service
					Years
	Nonvested stock options	$	8		1
	Restricted shares and time-vested restricted share units	9			1.3
	Nonvested performance-based restricted share units	58			1.4
	Excess tax benefits, resulting from tax deductions in excess of the compensation cost recognized, aggregating $50, $50 and $15 were classified as other cash inflows under Financing Activities in the Consolidated Cash Flow Statement for the years ended December 31, 2013, 2012 and 2011, respectively.
	A summary of stock-based compensation under the Plans is presented below:
	Stock Options	Shares		Weighted-				Weighted-		Aggregate
		(in thousands)		Average				Average		Intrinsic
				Exercise				Remaining		Value
				Price				Contractual
								Term
	Outstanding at January 1, 2013	9,268		$	65.38
	Granted	1,851		103.29
	Exercised	(3,661	)	63.13
	Forfeited or expired	(235	)	79.8
	Outstanding at December 31, 2013	7,223		75.77				6.6		$	207
	Exercisable at December 31, 2013	3,727		63.75				4.7		$	152
	The following summarizes the effect of the exercises of stock options:
		Year Ended December 31
		2013			2012				2011
	Cash received	$	232		$	565			$	435
	Income tax benefit received	44			49				13
	Intrinsic value	138			161				69
		Time-Vested						Performance-Based
		Restricted Share						Restricted Share
		Units						Units
	Other Stock-Based Awards	Shares		Weighted-				Shares			Weighted-
		(in thousands)		Average				(in thousands)			Average
				Grant-Date							Grant-Date
				Fair Value							Fair Value
	Nonvested at January 1, 2013	324		$	75.24			2,187			$	67.41
	Granted	75		89.29				713			100.42
	Vested	(117	)	70.39				(294	)		62.72
	Forfeited	(25	)	76.52				(523	)		64.75
	Nonvested at December 31, 2013	257		81.38				2,083			79.98
	The total fair value of restricted shares and restricted share units that were distributed to participants during 2013, 2012 and 2011 was $45, $101 and $28, respectively.

Employee_Postretirement_Benefi

Employee Postretirement Benefits	12 Months Ended
	Dec. 31, 2013
Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]	'
Employee Postretirement Benefits	'
	Employee Postretirement Benefits
	Pension Plans
	Substantially all regular employees in North America and the United Kingdom are covered by defined benefit pension plans (the "Principal Plans") and/or defined contribution retirement plans. Certain other subsidiaries have defined benefit pension plans or, in certain countries, termination pay plans covering substantially all regular employees. The funding policy for our qualified defined benefit pension plans is to contribute assets at least equal in amount to regulatory minimum requirements. Nonqualified U.S. plans providing pension benefits in excess of limitations imposed by the U.S. income tax code are not funded.
	Other Postretirement Benefit Plans
	Substantially all U.S. retirees and employees have access to our unfunded healthcare and life insurance benefit plans. The annual increase in the consolidated weighted-average healthcare cost trend rate is expected to be 6.2 percent in 2014 and to decline to 5.0 percent in 2022 and thereafter. Assumed healthcare cost trend rates affect the amounts reported for postretirement healthcare benefit plans. A one-percentage-point change in assumed healthcare trend rates would not have a significant effect.
	Summarized financial information about postretirement plans, excluding defined contribution retirement plans, is presented below:
		Pension Benefits								Other Benefits
		Year Ended December 31
		2013				2012				2013			2012
	Change in Benefit Obligation
	Benefit obligation at beginning of year	$	6,590			$	5,920			$	824		$	788
	Service cost	53				45				17			15
	Interest cost	257				279				32			36
	Actuarial loss (gain)	(422		)		854				(60		)	37
	Currency and other	47				79				—			3
	Benefit payments from plans	(343		)		(478		)		—			—
	Direct benefit payments	(13		)		(14		)		(52		)	(55		)
	Curtailment and settlements	(5		)		(95		)		—			—
	Benefit obligation at end of year	6,164				6,590				761			824
	Change in Plan Assets
	Fair value of plan assets at beginning of year	5,375				5,214				—			—
	Actual return on plan assets	268				556				—			—
	Employer contributions	220				110				—			—
	Currency and other	47				60				—			—
	Benefit payments	(343		)		(478		)		—			—
	Settlements	—				(87		)		—			—
	Fair value of plan assets at end of year	5,567				5,375				—			—
	Funded Status	$	(597	)		$	(1,215	)		$	(761	)	$	(824	)
	Amounts Recognized in the Balance Sheet
	Noncurrent asset—prepaid benefit cost	$	9			$	8			$	—		$	—
	Current liability—accrued benefit cost	(12		)		(12		)		(56		)	(56		)
	Noncurrent liability—accrued benefit cost	(594		)		(1,211		)		(705		)	(768		)
	Net amount recognized	$	(597	)		$	(1,215	)		$	(761	)	$	(824	)
	During 2012, we offered a lump-sum distribution to certain participants in our U.S. plan. Included in pension benefit payments from plans in 2012 is $116 related to participants electing the lump-sum option, which was not sufficient to trigger a settlement charge for our U.S. plan.
	Information for the Principal Plans and All Other Pension Plans
		Principal Plans								All Other							Total
										Pension Plans
		Year Ended December 31
		2013				2012				2013			2012				2013			2012
	Projected benefit obligation (“PBO”)	$	5,640			$	6,071			$	524		$	519			$	6,164		$	6,590
	Accumulated benefit obligation (“ABO”)	5,555				6,049				439			420				5,994			6,469
	Fair value of plan assets	5,205				5,063				362			312				5,567			5,375
	The PBO and fair value of plan assets for the Principal Plans include $3,866 and $3,565, respectively, related to the U.S. qualified and nonqualified pension plans as of December 31, 2013. The PBO and fair value of plan assets for the Principal Plans include $4,375 and $3,553, respectively, related to the U.S. qualified and nonqualified pension plans as of December 31, 2012.
	Information for Pension Plans with an ABO in Excess of Plan Assets
		December 31
		2013				2012
	PBO	$	5,722			$	6,558
	ABO	5,622				6,440
	Fair value of plan assets	5,163				5,335
	Components of Net Periodic Benefit Cost
		Pension Benefits											Other Benefits
		Year Ended December 31
		2013				2012				2011			2013				2012			2011
	Service cost	$	53			$	45			$	57		$	17			$	15		$	14
	Interest cost	257				279				307			32				36			41
	Expected return on plan assets(a)	(331		)		(329		)		(345		)	—				—			—
	Recognized net actuarial loss	120				111				94			3				1			—
	Curtailment and settlements	(31		)		20				—			—				—			—
	Other	1				(4		)		6			(2		)		(1		)	1
	Net periodic benefit cost	$	69			$	122			$	119		$	50			$	51		$	56
	(a)	The expected return on plan assets is determined by multiplying the fair value of plan assets at the remeasurement date, typically the prior year-end, and adjusted for estimated current year cash benefit payments and contributions, by the expected long-term rate of return.
	Weighted-Average Assumptions Used to Determine Net Cost for Years Ended December 31
		Pension Benefits									Other Benefits
	2013			2012			2011			2013		2012			2011
Discount rate	4.04	%		4.87	%		5.51	%		3.97	%	4.7	%		5.44	%
Expected long-term return on plan assets	6.26	%		6.49	%		7.14	%		—		—			—
Rate of compensation increase	2.73	%		2.91	%		4.05	%		—		—			—
Weighted-Average Assumptions Used to Determine Benefit Obligations at December 31
	Pension Benefits						Other Benefits
	2013			2012			2013			2012
Discount rate	4.66	%		4.04	%		4.97	%		3.97	%
Rate of compensation increase	2.67	%		2.73	%		—			—
Investment Strategies for the Principal Plans
Strategic asset allocation decisions are made considering several risk factors, including plan participants' retirement benefit security, the estimated payments of the associated liabilities, the plan funded status, and Kimberly-Clark's financial condition. The resulting strategic asset allocation is a diversified blend of equity and fixed income investments. Equity investments are typically diversified across geographies and market capitalization. Fixed income investments are diversified across multiple sectors including government issues and corporate debt instruments with a portfolio duration that is consistent with the estimated payment of the associated liability. Actual asset allocation is regularly reviewed and periodically rebalanced to the strategic allocation when considered appropriate. Our 2014 target plan asset allocation for the Principal Plans is 70 percent fixed income securities and 30 percent equity securities.
The expected long-term rate of return is evaluated on an annual basis. In setting this assumption, we consider a number of factors including projected future returns by asset class relative to the current asset allocation. The weighted-average expected long-term rate of return on pension fund assets used to calculate pension expense for the Principal Plans was 6.43 percent in 2013 compared with 6.68 percent in 2012 and will be 6.16 percent in 2014.
Set forth below are the pension plan assets of the Principal Plans measured at fair value, by level in the fair-value hierarchy:
	Fair Value Measurements at December 31, 2013
	Total				Quoted Prices				Significant			Significant Unobservable Inputs (Level 3)
					in Active				Observable
					Markets for				Inputs
					Identical Assets				(Level 2)
					(Level 1)
Cash and Cash Equivalents
Held directly	$	33			$	33			$	—		$	—
Held through mutual and pooled funds	173				34				139			—
Fixed Income
Held directly
U.S. government and municipals	211				71				140			—
U.S. corporate debt	1,654				—				1,654			—
U.S. securitized fixed income	8				—				8			—
Held through mutual and pooled funds
U.S. corporate debt	186				—				186			—
International bonds	1,089				—				1,089			—
Multi-sector	2				2				—			—
Equity
Held directly
U.S. equity	1				1				—			—
Held through mutual and pooled funds
U.S. equity	4				4				—			—
Non-U.S. equity	123				1				122			—
Global equity	1,691				—				1,691			—
Insurance Contract	30				—				—			30
Total Plan Assets	$	5,205			$	146			$	5,029		$	30
	Fair Value Measurements at December 31, 2012
	Total				Quoted Prices				Significant			Significant Unobservable Inputs (Level 3)
					in Active				Observable
					Markets for				Inputs
					Identical Assets				(Level 2)
					(Level 1)
Cash and Cash Equivalents
Held directly	$	23			$	23			$	—		$	—
Held through mutual and pooled funds	143				—				143			—
Fixed Income
Held directly
U.S. government and municipals	132				31				101			—
U.S. corporate debt	1,112				—				1,112			—
U.S. securitized fixed income	3				—				3			—
Held through mutual and pooled funds
U.S. government and municipals	490				—				490			—
U.S. corporate debt	199				—				199			—
International bonds	920				—				920			—
Multi-sector	2				2				—			—
Equity
Held directly
International equity	143				143				—			—
Held through mutual and pooled funds
U.S. equity	678				3				675			—
Non-U.S. equity	925				1				924			—
Global equity	293				—				293			—
Total Plan Assets	$	5,063			$	203			$	4,860		$	—
During 2013 and 2012, the plan assets did not include a significant amount of Kimberly-Clark common stock.
Inputs and valuation techniques used to measure the fair value of plan assets vary according to the type of security being valued. Substantially all of the equity securities held directly by the plans are actively traded and fair values are determined based on quoted market prices. Fair values of U.S. Treasury securities are determined based on trading activity in the marketplace.
Fair values of U.S. corporate debt, U.S. securitized fixed income and international bonds are typically determined by reference to the values of similar securities traded in the marketplace and current interest rate levels. Multiple pricing services are typically employed to assist in determining these valuations.
Fair values of equity securities and fixed income securities held through units of pooled funds are based on net asset value (NAV) of the units of the pooled fund determined by the fund manager. Pooled funds are similar in nature to retail mutual funds, but are typically more efficient for institutional investors than retail mutual funds. The fair value of pooled funds is determined by the value of the underlying assets held by the fund and the units outstanding. The value of the pooled fund is not directly observable, but is based on observable inputs.
Equity securities held directly by the pension trusts and those held through units in pooled funds are monitored as to issuer and industry. Except for U.S. Treasuries, concentrations of fixed income securities are similarly monitored for concentrations by issuer and industry. As of December 31, 2013, there were no significant concentrations of equity or debt securities in any single issuer or industry.
The insurance contract was purchased in December 2013, and fair value was determined based on an evaluation of various factors, including purchase price. No other level 3 transfers (in or out) were made in 2013 and 2012.
Cash Flows
We expect to contribute $100 to $200 to our defined benefit pension plans in 2014.
Estimated Future Benefit Payments
Over the next ten years, we expect that the following gross benefit payments will occur:
	Pension Benefits				Other Benefits
2014	$	369			$	57
2015	374				59
2016	374				60
2017	382				61
2018	386				63
2019-2023	2,005				326
Defined Contribution Pension Plans
Our 401(k) profit sharing plan and supplemental plan provide for a matching contribution of a U.S. employee's contributions and accruals, subject to predetermined limits, as well as a discretionary profit sharing contribution, in which contributions will be based on our profit performance. We also have defined contribution pension plans for certain employees outside the U.S.
Costs charged to expense for our defined contribution pension plans were as follows:
	2013				2012				2011
U.S.	$	90			$	82			$	77
Outside the U.S.	27				26				36
Total	$	117			$	108			$	113

Accumulated_Other_Comprehensiv

Accumulated Other Comprehensive Income	12 Months Ended
	Dec. 31, 2013
Equity [Abstract]	'
Stockholders' Equity	'
	Accumulated Other Comprehensive Income
	The changes in the components of AOCI attributable to Kimberly-Clark, net of tax, are as follows:
			Unrealized Translation				Defined Benefit Pension Plans				Other Postretirement Benefit Plans				Cash Flow Hedges and Other
	Balance as of December 31, 2011		$	(221	)		$	(1,578	)		$	(31	)		$	(36	)
	Other comprehensive income (loss) before reclassifications		195				(407		)		(20		)		(13		)
	(Income) loss reclassified from AOCI		—				57			(a)	(2		)	(a)	(3		)
	Net current period other comprehensive income (loss)		195				(350		)		(22		)		(16		)
	Balance as of December 31, 2012		(26		)		(1,928		)		(53		)		(52		)
	Other comprehensive income (loss) before reclassifications		(499		)		218				36				24
	(Income) loss reclassified from AOCI		—				42			(a)	2			(a)	(6		)
	Net current period other comprehensive income (loss)		(499		)		260				38				18
	Balance as of December 31, 2013		$	(525	)		$	(1,668	)		$	(15	)		$	(34	)
	(a)	Included in computation of net periodic pension and postretirement benefits costs (see Note 10)
	Included in the defined benefit pension plans and other postretirement benefit plans balances as of December 31, 2013 is $1,717 and $35 of unrecognized net actuarial loss and unrecognized prior service cost/credit, respectively, of which $98 and $3, respectively, are expected to be recognized as a component of net periodic benefit cost in 2014.
	The changes in the components of AOCI attributable to Kimberly-Clark, including the tax effect, are as follows:
		Year Ended December 31
		2013				2012				2011
	Unrealized translation	$	(495	)		$	204			$	(243	)
	Tax effect	(4		)		(9		)		7
		(499		)		195				(236		)
	Defined benefit pension plans
	Unrecognized net actuarial loss and transition amount
	Funded status recognition	356				(588		)		(396		)
	Amortization included in net periodic benefit cost	120				90				94
	Currency and other	(8		)		(20		)		(2		)
		468				(518		)		(304		)
	Unrecognized prior service cost/credit
	Funded status recognition	—				—				74
	Amortization included in net periodic benefit cost	(31		)		—				3
	Currency and other	(1		)		3				(4		)
		(32		)		3				73
	Tax effect	(176		)		165				99
		260				(350		)		(132		)
	Other postretirement benefit plans
	Unrecognized net actuarial loss and transition amount
	Funded status recognition	62				(31		)		(31		)
	Amortization included in net periodic benefit cost	3				(1		)		—
		65				(32		)		(31		)
	Unrecognized prior service cost/credit
	Funded status recognition	(3		)		—				31
	Amortization included in net periodic benefit cost	—				(2		)		1
		(3		)		(2		)		32
	Tax effect	(24		)		12				(2		)
		38				(22		)		(1		)
	Cash flow hedges and other
	Recognition of effective portion of hedges	37				(20		)		(81		)
	Amortization included in net income	(10		)		—				39
	Currency and other	4				(1		)		(13		)
		31				(21		)		(55		)
	Tax effect	(13		)		5				24
		18				(16		)		(31		)
	Change in AOCI	$	(183	)		$	(193	)		$	(400	)
	Amounts are reclassified from AOCI into cost of products sold, marketing, research and general expenses, interest expense or other (income) and expense, net, as applicable, in the Consolidated Income Statement.
	Net unrealized currency gains or losses resulting from the translation of assets and liabilities of foreign subsidiaries, except those in highly inflationary economies, are recorded in AOCI. For these operations, changes in exchange rates generally do not affect cash flows; therefore, unrealized translation adjustments are recorded in AOCI rather than net income. Upon sale or substantially complete liquidation of any of these subsidiaries, the applicable unrealized translation adjustment would be removed from AOCI and reported as part of the gain or loss on the sale or liquidation. The change in unrealized translation in 2013 is primarily due to the strengthening of the U.S. dollar versus the Australian dollar and Brazilian real, as well as most other foreign currencies. Also included in unrealized translation amounts are the effects of foreign exchange rate changes on intercompany balances of a long-term investment nature and transactions designated as hedges of net foreign investments.

Leases_and_Commitments

Leases and Commitments	12 Months Ended
	Dec. 31, 2013
Leases and Commitments	'
Leases and Commitments	'
	Leases and Commitments
	We have entered into operating leases for certain warehouse facilities, automobiles and equipment. The future minimum obligations under operating leases having a noncancelable term in excess of one year are as follows:
		Year Ending December 31
	2014	$	189
	2015	155
	2016	124
	2017	113
	2018	76
	Thereafter	107
	Future minimum obligations	$	764
	Consolidated rental expense under operating leases was $333, $283 and $278 in 2013, 2012 and 2011, respectively.
	We have entered into long-term contracts for the purchase of pulp and utilities, principally electricity. Commitments under these contracts based on current prices are $481 in 2014, $259 in 2015, $189 in 2016, $173 in 2017 and $177 in 2018. Total commitments beyond the year 2018 are $334.
	Although we are primarily liable for payments on the above-mentioned leases and purchase commitments, our exposure to losses, if any, under these arrangements is not material.

Legal_Matters

Legal Matters	12 Months Ended
	Dec. 31, 2013
Legal Matters	'
Legal Matters	'
	Legal Matters
	We are subject to various legal proceedings, claims and governmental inquiries, inspections, audits or investigations pertaining to issues such as contract disputes, product liability, tax matters, patents and trademarks, advertising, pricing, business practices, governmental regulations, employment and other matters. Although the results of litigation and claims cannot be predicted with certainty, we believe that the ultimate disposition of these matters, to the extent not previously provided for, will not have a material adverse effect, individually or in the aggregate, on our business, financial condition, results of operations or liquidity.

Objectives_and_Strategies_for_

Objectives and Strategies for Using Derivatives	12 Months Ended
	Dec. 31, 2013
Objectives and Strategies for Using Derivatives	'
Objectives and Strategies for Using Derivatives	'
	Objectives and Strategies for Using Derivatives
	As a multinational enterprise, we are exposed to financial risks, such as changes in foreign currency exchange rates, interest rates, and commodity prices. We employ a number of practices to manage these risks, including operating and financing activities and, where appropriate, the use of derivative instruments. We enter into derivative instruments to hedge a portion of forecasted cash flows denominated in foreign currencies for non-U.S. operations' purchases of raw materials, which are priced in U.S. dollars, and imports of intercompany finished goods and work-in-process priced predominantly in U.S. dollars and euros. The derivative instruments used to manage these exposures are designated and qualify as cash flow hedges. The foreign currency exposure on certain non-functional currency denominated monetary assets and liabilities, primarily intercompany loans and accounts payable, is hedged with primarily undesignated derivative instruments. Interest rate risk is managed using a portfolio of variable- and fixed-rate debt composed of short- and long-term instruments. Interest rate swap contracts may be used to facilitate the maintenance of the desired ratio of variable- and fixed-rate debt and are designated and qualify as fair value hedges. From time to time, we also hedge the anticipated issuance of fixed-rate debt, using forward-starting swaps, and these contracts are designated as cash flow hedges. We use derivative instruments, such as forward swap contracts, to hedge a limited portion of our exposure to market risk arising from changes in prices of certain commodities. These derivatives are designated as cash flow hedges of specific quantities of the underlying commodity expected to be purchased in future months. Translation adjustments result from translating foreign entities' financial statements into U.S. dollars from their functional currencies. The risk to any particular entity's net assets is reduced to the extent that the entity is financed with local currency borrowing. Translation exposure, which results from changes in translation rates between functional currencies and the U.S. dollar, generally is not hedged.
	Set forth below is a summary of the total designated and undesignated fair values of our derivative instruments:
		Assets				Liabilities
		2013		2012		2013		2012
	Foreign currency exchange contracts	$	34	$	52	$	49	$	17
	Interest rate contracts	22		7		—		43
	Commodity price contracts	6		2		—		3
	Total	$	62	$	61	$	49	$	63
	The derivative assets are included in the Consolidated Balance Sheet in other current assets and other assets, as appropriate. The derivative liabilities are included in the Consolidated Balance Sheet in accrued expenses and other liabilities, as appropriate.
	Effect of Derivative Instruments on Results of Operations and Other Comprehensive Income
	Derivative instruments that are designated and qualify as fair value hedges are predominantly used to manage interest rate risk. The fair values of these derivative instruments are recorded as an asset or liability, as appropriate, with the offset recorded in current earnings. The offset to the change in fair values of the related hedged items also is recorded in current earnings. Any realized gain or loss on the derivatives that hedge interest rate risk is amortized to interest expense over the life of the related debt. At December 31, 2013, the aggregate notional values of outstanding interest rate contracts designated as fair value hedges were $250. Fair value hedges resulted in no significant ineffectiveness in each of the three years ended December 31, 2013. For each of the three years ended December 31, 2013, gains or losses recognized in interest expense for interest rates swaps were not significant. For each of the three years ended December 31, 2013, no gain or loss was recognized in earnings as a result of a hedged firm commitment no longer qualifying as a fair value hedge.
	For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain or loss on the derivative instrument is initially recorded in AOCI, net of related income taxes, and recognized in earnings in the same period that the hedged exposure affects earnings. As of December 31, 2013, outstanding commodity forward contracts were in place to hedge a limited portion of our estimated requirements of the related underlying commodities in 2014 and future periods. As of December 31, 2013, the aggregate notional values of outstanding foreign exchange and interest rate derivative contracts designated as cash flow hedges were $1 billion and $200, respectively. Cash flow hedges resulted in no significant ineffectiveness in each of the three years ended December 31, 2013. For each of the three years ended December 31, 2013, no gains or losses were reclassified into earnings as a result of the discontinuance of cash flow hedges due to the original forecasted transaction no longer being probable of occurring. At December 31, 2013, amounts to be reclassified from AOCI during the next twelve months are not expected to be material. The maximum maturity of cash flow hedges in place at December 31, 2013 is January 2016.
	Gains or losses on undesignated foreign exchange hedging instruments are immediately recognized in other (income) and expense, net. Losses of $75 and gains of $67 and $3 were recorded in the years ending December 31, 2013, 2012 and 2011, respectively. The effect on earnings from the use of these non-designated derivatives is substantially neutralized by the transactional gains and losses recorded on the underlying assets and liabilities. At December 31, 2013, the notional amount of these undesignated derivative instruments was $2.4 billion.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2013
Income Tax Expense (Benefit) [Abstract]	'
Income Taxes	'
	Income Taxes
	An analysis of the provision for income taxes follows:
		Year Ended December 31
		2013				2012				2011
	Current income taxes
	United States	$	350			$	182			$	43
	State	110				30				32
	Other countries	318				332				311
	Total	778				544				386
	Deferred income taxes
	United States	85				204				254
	State	14				34				29
	Other countries	52				(14		)		(9		)
	Total	151				224				274
	Total provision for income taxes	$	929			$	768			$	660
	Income before income taxes is earned in the following tax jurisdictions:
		Year Ended December 31
		2013				2012				2011
	United States	$	1,764			$	1,415			$	1,317
	Other countries	1,181				1,005				866
	Total income before income taxes	$	2,945			$	2,420			$	2,183
	Deferred income tax assets and liabilities are composed of the following:
			31-Dec
			2013				2012
	Deferred tax assets
	Pension and other postretirement benefits		$	728			$	972
	Tax credits and loss carryforwards		604				729
	Property, plant and equipment, net		104				110
	Other		516				492
			1,952				2,303
	Valuation allowance		(197		)		(215		)
	Total deferred assets		1,755				2,088
	Deferred tax liabilities
	Pension and other postretirement benefits		259				269
	Property, plant and equipment, net		1,244				1,228
	Installment sales		6				120
	Investments in subsidiaries		205				108
	Other		390				385
	Total deferred tax liabilities		2,104				2,110
	Net deferred tax assets (liabilities)		$	(349	)		$	(22	)
	Valuation allowances at the end of 2013 primarily relate to tax credits and income tax loss carryforwards of $1.0 billion. If these items are not utilized against taxable income, $368 of the loss carryforwards will expire from 2014 through 2031. The remaining $654 have no expiration date.
	Realization of income tax loss carryforwards is dependent on generating sufficient taxable income prior to expiration of these carryforwards. Although realization is not assured, we believe it is more likely than not that all of the deferred tax assets, net of applicable valuation allowances, will be realized. The amount of the deferred tax assets considered realizable could be reduced or increased due to changes in the tax environment or if estimates of future taxable income change during the carryforward period.
	Presented below is a reconciliation of the income tax provision computed at the U.S. federal statutory tax rate to the actual effective tax rate:
		Year Ended December 31
		2013			2012			2011
	U.S. statutory rate applied to income before income taxes	35	%		35	%		35	%
	Rate of state income taxes, net of federal tax benefit	2.7			1.7			1.8
	Statutory rates other than U.S. statutory rate	(2.9	)		(2.8	)		(2.3	)
	Other - net(a)	(3.3	)		(2.2	)		(4.3	)
	Effective income tax rate	31.5	%		31.7	%		30.2	%
	(a)	Other - net is comprised of numerous items, none of which is greater than 1.75 percent of income before income taxes.
	At December 31, 2013, U.S. income taxes and foreign withholding taxes have not been provided on $9.8 billion of unremitted earnings of subsidiaries operating outside the U.S. These earnings, which are considered to be invested indefinitely, would become subject to income tax if they were remitted as dividends, were lent to one of our U.S. entities, or if we were to sell our stock in the subsidiaries. Determination of the amount of unrecognized deferred U.S. income tax liability on these unremitted earnings is not practicable because of the complexities associated with this hypothetical calculation. We do not expect restrictions or taxes on repatriation of cash held outside of the United States to have a material effect on our overall liquidity, financial condition or results of operations in the foreseeable future.
	Presented below is a reconciliation of the beginning and ending amounts of unrecognized income tax benefits:
		2013				2012				2011
	Balance at January 1	$	435			$	558			$	568
	Gross increases for tax positions of prior years	73				30				17
	Gross decreases for tax positions of prior years	(31		)		(104		)		(60		)
	Gross increases for tax positions of the current year	37				52				55
	Settlements	(35		)		(100		)		(15		)
	Other	(6		)		(1		)		(7		)
	Balance at December 31	$	473			$	435			$	558
	Of the amounts recorded as unrecognized tax benefits at December 31, 2013, $309 would reduce our effective tax rate if recognized.
	We recognize accrued interest and penalties related to unrecognized tax benefits in income tax expense. During the years ended December 31, 2013, 2012 and 2011, the net cost in interest and penalties was not significant. Total accrued penalties and net accrued interest was $42 and $47 at December 31, 2013 and 2012, respectively.
It is reasonably possible that a number of uncertainties could be resolved within the next 12 months, the most significant of which involves tax credits. It is reasonably possible the aggregate resolution of the uncertainties could be up to $180, while none of the uncertainties is individually significant. Resolution of these matters is not expected to have a material effect on our financial condition, results of operations or liquidity.
As of December 31, 2013, the following tax years remain subject to examination for the major jurisdictions where we conduct business:
Jurisdiction	Years
United States	2010 to 2013
United Kingdom	2012 to 2013
Canada	2010 to 2013
Korea	2008 to 2013
Australia	2009 to 2013
Our U.S. federal income tax returns have been audited through 2009. We have various federal income tax return positions in administrative appeals or litigation for 1999 to 2009.
State income tax returns are generally subject to examination for a period of 3 to 5 years after filing of the respective return. The state effect of any changes to filed federal positions remains subject to examination by various states for a period of up to two years after formal notification to the states. We have various state income tax return positions in the process of examination, administrative appeals or litigation.

Earnings_Per_Share

Earnings Per Share	12 Months Ended
	Dec. 31, 2013
Earnings Per Share [Abstract]	'
Earnings Per Share	'
	Earnings Per Share ("EPS")
	There are no adjustments required to be made to net income for purposes of computing basic and diluted EPS. The average number of common shares outstanding is reconciled to those used in the basic and diluted EPS computations as follows:
	(Millions of shares)		2013	2012		2011
	Average shares outstanding		384	393		395.4
	Participating securities		—	—		0.3
	Basic		384	393		395.7
	Dilutive effect of stock options and restricted share unit awards		3.3	3.1		2.9
	Diluted		387.3	396.1		398.6
	Options outstanding that were not included in the computation of diluted EPS mainly because their exercise price was greater than the average market price of the common shares are summarized below:
		2013		2012			2011
	Average number of share equivalents (millions)	1.1		1.1			3.6
	Weighted-average exercise price	$	103.29	$	78.54		$	71.49
	Options outstanding at year-end (millions)	1.8		1.7			3
	The number of common shares outstanding as of December 31, 2013, 2012 and 2011 was 380.8 million, 389.3 million and 395.7 million, respectively.

Description_of_Business_Segmen

Description of Business Segments	12 Months Ended
	Dec. 31, 2013
Description of Business Segments	'
Description of Business Segments	'
	Business Segment Information
	We are organized into operating segments based on product groupings. These operating segments have been aggregated into four reportable global business segments: Personal Care, Consumer Tissue, KCP and Health Care. The reportable segments were determined in accordance with how our executive managers develop and execute global strategies to drive growth and profitability. These strategies include global plans for branding and product positioning, technology, research and development programs, cost reductions including supply chain management, and capacity and capital investments for each of these businesses. Segment management is evaluated on several factors, including operating profit. Segment operating profit excludes other (income) and expense, net and income and expense not associated with the business segments, including the charges related to the European strategic changes and the pulp and tissue restructuring actions described in Notes 3 and 4, respectively.
	The principal sources of revenue in each global business segment are described below:
	•	Personal Care brands offer parents a trusted partner in caring for their families and deliver confidence, protection and discretion to adults through a wide variety of innovative solutions and products such as disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, and other related products. Products in this segment are sold under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Kotex, U by Kotex, Intimus, Depend, Plenitud, Poise and other brand names.
	•	Consumer Tissue offers a wide variety of innovative solutions and trusted brands that touch and improve people's lives every day.  Products in this segment include facial and bathroom tissue, paper towels, napkins and related products, and are sold under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve and other brand names.
	•	K-C Professional helps transform workplaces for employees and patrons, making them healthier, safer and more productive, through a range of solutions and supporting products such as apparel, wipers, soaps, sanitizers, tissue and towels.  Key brands in this segment include Kleenex, Scott, WypAll, Kimtech and Jackson Safety.
	•	Health Care provides essentials that help restore patients to better health and improve the quality of patients' lives. This segment offers surgical and infection prevention products for the operating room, and a portfolio of innovative medical devices focused on pain management, respiratory and digestive health. This business is a global leader in education to prevent healthcare-associated infections. Products are sold primarily under the Kimberly-Clark and ON-Q brand names. As described in Note 2, our Board of Directors has authorized management to pursue a potential tax-free spin-off of our health care business, with a current target to complete the spin-off by the end of the third quarter of 2014.
	Net sales to Wal-Mart Stores, Inc. were approximately 12 percent in 2013, 2012 and 2011.
	Information concerning consolidated operations by business segment is presented in the following tables:
	Consolidated Operations by Business Segment
		Personal			Consumer			K-C			Health		Corporate				Consolidated
		Care			Tissue			Professional			Care		& Other				Total
	Net Sales(a)
	2013	$	9,536		$	6,637		$	3,323		$	1,618	$	38			$	21,152
	2012	9,576			6,527			3,283			1,622		55				21,063
	2011	9,128			6,770			3,294			1,606		48				20,846
	Operating Profit(b)
	2013	1,698			988			608			230		(316		)	(c)	3,208
	2012	1,660			887			545			229		(635		)	(c)	2,686
	2011	1,526			775			487			219		(565		)	(c)	2,442
	Depreciation and Amortization
	2013	332			318			138			71		4				863
	2012	315			331			141			59		11				857
	2011	296			541			187			55		12				1,091
	Assets
	2013	6,623			5,483			2,431			2,370		2,012				18,919
	2012	7,014			5,531			2,739			2,531		2,058				19,873
	2011	6,582			5,685			2,783			2,529		1,794				19,373
	Capital Spending
	2013	461			328			118			44		2				953
	2012	551			352			116			42		32				1,093
	2011	543			255			114			53		3				968
	(a)	Net sales in the United States to third parties totaled $9,783, $9,720 and $9,715 in 2013, 2012 and 2011, respectively.
	(b)	Segment operating profit excludes other (income) and expense, net and income and expenses not associated with the business segments.
	(c)	Corporate & Other includes the following charges:
		Year Ended December 31
		2013			2012								2011
		European Strategic			European Strategic			Pulp and Tissue			Total		Pulp and Tissue
		Changes			Changes			Restructuring Actions					Restructuring Actions
	Personal Care	$	36		$	213		$	—		$	213	$	—
	Consumer Tissue	27			66			125			191		357
	K-C Professional	13			20			9			29		56
	Other (income) and expense, net	5			—			1			1		2
	Total	$	81		$	299		$	135		$	434	$	415
	In addition, Corporate and Other for the year ended December 31, 2013 includes a pre-tax charge of $36 related to the devaluation of the Venezuelan bolivar and for the year ended December 31, 2011 includes a non-deductible business tax charge of $32 related to a law change in Colombia.
	Sales of Principal Products
	(Billions of dollars)		2013			2012			2011
	Consumer tissue products		$	6.6		$	6.5		$	6.7
	Baby and child care products		7			7.1			6.8
	Away-from-home professional products		3.3			3.3			3.3
	All other		4.3			4.2			4
	Consolidated		$	21.2		$	21.1		$	20.8

Supplemental_Data

Supplemental Data	12 Months Ended
	Dec. 31, 2013
Supplemental Data	'
Supplemental Data	'
	Supplemental Data
	Supplemental Income Statement Data
		Year Ended December 31
		2013			2012			2011
	Advertising expense	$	777		$	810		$	686
	Research expense	360			356			316
	Equity Companies' Data
		Net			Gross			Operating			Net			Corporation's
		Sales			Profit			Profit			Income			Share of Net
														Income
	2013	$	2,638		$	950		$	642		$	426		$	205
	2012	2,514			864			567			368			176
	2011	2,446			796			514			335			161
		Current			Non-			Current			Non-			Stockholders'
		Assets			Current			Liabilities			Current			Equity
					Assets						Liabilities
	2013	$	1,197		$	1,124		$	847		$	845		$	629
	2012	1,054			1,068			712			837			573
	2011	1,000			906			491			872			543
	Equity companies are principally engaged in operations in the personal care and consumer tissue businesses, and amounts above primarily reflect operations in Latin America.
	At December 31, 2013, our equity companies and ownership interest were as follows: Kimberly-Clark Lever Private Limited (India) (50%), Kimberly-Clark de Mexico, S.A.B. de C.V. and subsidiaries (47.9%), Olayan Kimberly-Clark Arabia (49%), Olayan Kimberly-Clark (Bahrain) WLL (49%) and Tecnosur S.A. (Colombia) (50%).
	Kimberly-Clark de Mexico, S.A.B. de C.V. is partially owned by the public and its stock is publicly traded in Mexico. At December 31, 2013, our investment in this equity company was $269, and the estimated fair value of the investment was $4.3 billion based on the market price of publicly traded shares.
	At December 31, 2013, unremitted net income of equity companies included in consolidated retained earnings was $1.1 billion.
	Supplemental Balance Sheet Data
		December 31
	Summary of Accounts Receivable, Net	2013			2012
	From customers	$	2,345		$	2,346
	Other	271			376
	Less allowance for doubtful accounts and sales discounts	(71		)	(80		)
	Total	$	2,545		$	2,642
		December 31
		2013									2012
	Summary of Inventories by Major Class	LIFO			Non-			Total			LIFO			Non-		Total
					LIFO									LIFO
	At the lower of cost, determined on the FIFO or weighted-average cost methods, or market
	Raw materials	$	143		$	319		$	462		$	148		$	346	$	494
	Work in process	189			97			286			194			135		329
	Finished goods	648			753			1,401			656			786		1,442
	Supplies and other	—			326			326			—			314		314
		980			1,495			2,475			998			1,581		2,579
	Excess of FIFO or weighted-average cost over LIFO cost	(242		)	—			(242		)	(231		)	—		(231		)
	Total	$	738		$	1,495		$	2,233		$	767		$	1,581	$	2,348
		December 31
	Summary of Property, Plant and Equipment, Net	2013			2012
	Land	$	196		$	199
	Buildings	2,776			2,732
	Machinery and equipment	14,193			13,993
	Construction in progress	515			732
		17,680			17,656
	Less accumulated depreciation	(9,732		)	(9,561		)
	Total	$	7,948		$	8,095
	Property, plant and equipment, net in the United States as of December 31, 2013 and 2012 was $3,917, and $4,040 respectively.
		December 31
	Summary of Accrued Expenses	2013			2012
	Accrued advertising and promotion	$	355		$	372
	Accrued salaries and wages	471			456
	Accrued rebates	358			340
	Accrued taxes - income and other	336			336
	Other	540			740
	Total	$	2,060		$	2,244
	Supplemental Cash Flow Statement Data
	Summary of Cash Flow Effects of Decrease (Increase) in Operating Working Capital	Year Ended December 31
		2013			2012			2011
Accounts receivable	$	4		$	(38	)	$	(169	)
Inventories	100			9			9
Prepaid expenses	7			1			(19		)
Trade accounts payable	128			45			161
Accrued expenses	(177		)	133			(91		)
Accrued income taxes	(90		)	13			(107		)
Derivatives	5			(86		)	33
Currency	(135		)	42			(79		)
Total	$	(158	)	$	119		$	(262	)
	Year Ended December 31
Other Cash Flow Data	2013			2012			2011
Interest paid	$	307		$	299		$	273
Income taxes paid	776			451			463

Valuation_and_Qualifying_Accou

Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2013
Valuation and Qualifying Accounts	'
Valuation and Qualifying Accounts	'
	KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES
	SCHEDULE II
	VALUATION AND QUALIFYING ACCOUNTS
	FOR THE YEARS ENDED DECEMBER 31, 2013, 2012 AND 2011
	(Millions of dollars)
	Description	Balance at		Additions						Deductions
		Beginning
		of Period		Charged to			Charged to			Write-Offs and				Balance
				Costs and			Other			Reclassifications				at End of
				Expenses			Accounts(a)							Period
	December 31, 2013
	Allowances deducted from assets to which they apply
	Allowance for doubtful accounts	$	60	$	—		$	(4	)	$	5		(b)	$	51
	Allowances for sales discounts	20		275			(1		)	274			(c)	20
	December 31, 2012
	Allowances deducted from assets to which they apply
	Allowance for doubtful accounts	$	57	$	9		$	—		$	6		(b)	$	60
	Allowances for sales discounts	21		280			—			281			(c)	20
	December 31, 2011
	Allowances deducted from assets to which they apply
	Allowance for doubtful accounts	$	62	$	5		$	(5	)	$	5		(b)	$	57
	Allowances for sales discounts	18		275			—			272			(c)	21
	(a)	Includes bad debt recoveries and the effects of changes in foreign currency exchange rates.
	(b)	Primarily uncollectible receivables written off.
	(c)	Sales discounts allowed.
				Additions
	Description	Balance at		Charged to			Charged to			Deductions(a)				Balance
		Beginning		Costs and			Other							at End
		of Period		Expenses			Accounts							of  Period
	December 31, 2013
	Deferred taxes
	Valuation allowance	$	215	$	(11	)	$	—		$	7			$	197
	December 31, 2012
	Deferred taxes
	Valuation allowance	$	229	$	(18	)	$	—		$	(4	)		$	215
	December 31, 2011
	Deferred taxes
	Valuation allowance	$	287	$	(51	)	$	—		$	7			$	229
	(a)	Represents the net currency effects of translating valuation allowances at current rates of exchange.

Accounting_Policies_Policy

Accounting Policies (Policy)	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting periods. Actual results could differ from these estimates, and changes in these estimates are recorded when known. Estimates are used in accounting for, among other things, consumer and trade promotion and rebate accruals, pension and other postretirement benefits, future cash flows associated with impairment testing for goodwill and long-lived assets, and deferred tax assets and potential income tax assessments.
Cash Equivalents	'
	Cash Equivalents
	Cash equivalents are short-term investments with an original maturity date of three months or less.
Inventories and Distribution Costs	'
	Inventories and Distribution Costs
	Most U.S. inventories are valued at the lower of cost, using the Last-In, First-Out (LIFO) method, or market. The balance of the U.S. inventories and inventories of consolidated operations outside the U.S. are valued at the lower of cost, using either the First-In, First-Out (FIFO) or weighted-average cost methods, or market. Distribution costs are classified as cost of products sold.
Property and Depreciation	'
	Property and Depreciation
	Property, plant and equipment are stated at cost and are depreciated on the straight-line method. Buildings are depreciated over their estimated useful lives, primarily 40 years. Machinery and equipment are depreciated over their estimated useful lives, primarily ranging from 16 to 20 years. Purchases of computer software, including external costs and certain internal costs (including payroll and payroll-related costs of employees) directly associated with developing significant computer software applications for internal use, are capitalized. Computer software costs are amortized on the straight-line method over the estimated useful life of the software, which generally does not exceed 5 years.
	Estimated useful lives are periodically reviewed and, when warranted, changes are made to them. Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. An impairment loss would be indicated when estimated undiscounted future cash flows from the use and eventual disposition of an asset group, which are identifiable and largely independent of the cash flows of other asset groups, are less than the carrying amount of the asset group. Measurement of an impairment loss would be based on the excess of the carrying amount of the asset group over its fair value. Fair value is measured using discounted cash flows or independent appraisals, as appropriate. When property is sold or retired, the cost of the property and the related accumulated depreciation are removed from the Consolidated Balance Sheet and any gain or loss on the transaction is included in income.
Goodwill and Other Intangible Assets	'
	Goodwill and Other Intangible Assets
	Goodwill represents costs in excess of fair values assigned to the underlying net assets of acquired businesses. Goodwill is not amortized, but rather is tested for impairment annually and whenever events and circumstances indicate that impairment may have occurred. During the third quarter of 2013, we changed the measurement date for our annual goodwill impairment test from the beginning of the fourth quarter to the beginning of the third quarter. This change did not result in the delay, acceleration or avoidance of an impairment charge. We believe this timing is preferable as it better aligns the goodwill impairment test with our strategic business planning process, which is a key component of the goodwill impairment test. The change was applied prospectively, as retrospective application would have been impractical because we are unable to objectively select assumptions that would have been used in previous periods without the benefit of hindsight.
	Impairment testing compares the reporting unit carrying amount of goodwill with its fair value. Fair value is estimated based on discounted cash flows. If the reporting unit carrying amount of goodwill exceeds its fair value, an impairment charge would be recorded. We have completed the required annual testing of goodwill for impairment for all reporting units and have determined that goodwill is not impaired.
	Intangible assets with finite lives are amortized over their estimated useful lives and are reviewed for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. Estimated useful lives range from 2 to 30 years for trademarks, 5 to 17 years for patents and developed technologies, and 5 to 16 years for other intangible assets. An impairment loss would be indicated when estimated undiscounted future cash flows from the use of the asset are less than its carrying amount. An impairment loss would be measured as the difference between the fair value (based on discounted future cash flows) and the carrying amount of the asset.
Investments in Equity Companies	'
	Investments in Equity Companies
	Investments in companies which we do not control but over which we have the ability to exercise significant influence and that, in general, are at least 20 percent-owned by us, are stated at cost plus equity in undistributed net income. These investments are evaluated for impairment when warranted. An impairment loss would be recorded whenever a decline in value of an equity investment below its carrying amount is determined to be other than temporary. In judging "other than temporary," we would consider the length of time and extent to which the fair value of the equity company investment has been less than the carrying amount, the near-term and longer-term operating and financial prospects of the equity company, and our longer-term intent of retaining the investment in the equity company.
Revenue Recognition	'
	Revenue Recognition
	Sales revenue is recognized at the time of product shipment or delivery, depending on when title passes, to unaffiliated customers, and when all of the following have occurred: a firm sales agreement is in place, pricing is fixed or determinable, and collection is reasonably assured. Sales are reported net of returns, consumer and trade promotions, rebates and freight allowed. Taxes imposed by governmental authorities on our revenue-producing activities with customers, such as sales taxes and value-added taxes, are excluded from net sales.
Sales Incentives and Trade Promotion Allowances	'
	Sales Incentives and Trade Promotion Allowances
	The cost of promotion activities provided to customers is classified as a reduction in sales revenue. In addition, the estimated redemption value of consumer coupons is recorded at the time the coupons are issued and classified as a reduction in sales revenue. Estimates of trade promotion liabilities for promotional program costs incurred, but unpaid, are generally based on estimates of the quantity of customer sales, timing of promotional activities and forecasted costs for activities within the promotional programs.
Advertising Expense	'
	Advertising Expense
	Advertising costs are expensed in the year the related advertisement or campaign is first presented by the media. For interim reporting purposes, advertising expenses are charged to operations as a percentage of sales based on estimated sales and related advertising expense for the full year.
Research Expense	'
	Research Expense
	Research and development costs are charged to expense as incurred.
Environmental Expenditures	'
	Environmental Expenditures
	Environmental expenditures related to current operations that qualify as property, plant and equipment or which substantially increase the economic value or extend the useful life of an asset are capitalized, and all other environmental expenditures are expensed as incurred. Liabilities are recorded when environmental assessments and/or remedial efforts are probable and the costs can be reasonably estimated. Generally, the timing of these accruals coincides with completion of a feasibility study or a commitment to a formal plan of action. Liabilities for future expenditures for environmental remediation obligations are not discounted and do not reflect any anticipated recoveries from insurers.
Foreign Currency Translation	'
	Foreign Currency Translation
	The income statements of foreign operations, other than those in highly inflationary economies, are translated into U.S. dollars at rates of exchange in effect each month. The balance sheets of these operations are translated at period-end exchange rates, and the differences from historical exchange rates are reflected in stockholders' equity as unrealized translation adjustments.
	The income statements and balance sheets of operations in highly inflationary economies are translated into U.S. dollars using both current and historical rates of exchange. We account for our operations in Venezuela using highly inflationary accounting.
Derivative Instruments and Hedging	'
	Derivative Instruments and Hedging
	All derivative instruments are recorded as assets or liabilities on the balance sheet at fair value. Changes in the fair value of derivatives are either recorded in the income statement or other comprehensive income, as appropriate. The gain or loss on derivatives designated as fair value hedges and the offsetting loss or gain on the hedged item attributable to the hedged risk are included in income in the period that changes in fair value occur. The effective portion of the gain or loss on derivatives designated as cash flow hedges is included in other comprehensive income in the period that changes in fair value occur, and is reclassified to income in the same period that the hedged item affects income. The gain or loss on derivatives designated as hedges of investments in foreign subsidiaries is recognized in other comprehensive income to offset the change in value of the net investments being hedged. Any ineffective portion of cash flow hedges and net investment hedges is immediately recognized in income. Certain foreign-currency derivative instruments not designated as hedging instruments have been entered into to manage a portion of our foreign currency transactional exposures. The gain or loss on these derivatives is included in income in the period that changes in their fair values occur. Our policies allow the use of derivatives for risk management purposes and prohibit their use for speculation. Our policies also prohibit the use of any leveraged derivative instrument. Consistent with our policies, foreign currency derivative instruments, interest rate swaps and locks, and the majority of commodity hedging contracts are entered into with major financial institutions. At inception we formally designate certain derivatives as cash flow, fair value or net investment hedges and establish how the effectiveness of these hedges will be assessed and measured. This process links the derivatives to the transactions or financial balances they are hedging. Changes in the fair value of derivatives not designated as hedging instruments are recorded in earnings as they occur. See Note 14 for disclosures about derivative instruments and hedging activities.

European_Strategic_Changes_Eur

European Strategic Changes European Strategic Changes (Tables) (European Strategic Changes [Member])	12 Months Ended
	Dec. 31, 2013
European Strategic Changes [Member]	'
Restructuring Cost and Reserve	'
Charges incurred in Connection With Restructuring	'
		Year Ended December 31
		2013				2012
	Asset impairments	$	22			$	147
	Charges for workforce reductions	10				77
	Asset write-offs	13				10
	Incremental depreciation	18				8
	Benefit from pension curtailment	(31		)		—
	Other exit costs	22				8
	Cost of products sold	54				250
	Charges for workforce reductions and other exit costs included in marketing, research and general expenses and other (income) and expense, net	27				49
	Provision for income taxes	(15		)		(57		)
	Net charges	$	66			$	242
Schedule of Cash Charges Reconciled to Accrued Expenses	'
			2013				2012
	Accrued expenses - January 1		$	133			$	—
	Charges for workforce reductions and other exit costs		69				134
	Cash payments		(156		)		(4		)
	Currency and other		(9		)		3
	Accrued expenses - December 31		$	37			$	133

Fair_Value_Information_Tables

Fair Value Information (Tables)	12 Months Ended
	Dec. 31, 2013
Fair Value Disclosures [Abstract]	'
Fair Value Assets and Liabilities Measured on a Recurring Basis	'
	Set forth below are the assets and liabilities that are measured on a recurring basis at fair value and the inputs used to develop those fair value measurements.
		31-Dec-13				Fair Value Measurements
						Level 1				Level 2				Level 3
	Assets
	Company-owned life insurance ("COLI")	$	55			$	—			$	55			$	—
	Available-for-sale securities	22				22				—				—
	Derivatives	62				—				62				—
	Total	$	139			$	22			$	117			$	—
	Liabilities
	Derivatives	$	49			$	—			$	49			$	—
		31-Dec-12				Fair Value Measurements
						Level 1				Level 2				Level 3
	Assets
	COLI	$	49			$	—			$	49			$	—
	Available-for-sale securities	17				17				—				—
	Derivatives	61				—				61				—
	Total	$	127			$	17			$	110			$	—
	Liabilities
	Derivatives	$	63			$	—			$	63			$	—
Fair Value, by Balance Sheet Grouping	'
	The following table includes the fair value of our financial instruments for which disclosure of fair value is required:
		Fair Value		Carrying				Estimated				Carrying				Estimated
		Hierarchy		Amount				Fair				Amount				Fair
		Level						Value								Value
				December 31, 2013								December 31, 2012
	Assets
	Cash and cash equivalents(a)	1		$	1,054			$	1,054			$	1,106			$	1,106
	Time deposits(b)	1		222				222				224				224
	Note receivable(c)	3		16				16				395				392
	Liabilities and redeemable securities of subsidiaries
	Short-term debt(d)	2		63				63				359				359
	Monetization loan(c)	3		—				—				397				400
	Long-term debt(e)	2		5,698				6,271				5,429				6,527
	Redeemable preferred securities of subsidiaries(c)	3		532				552				506				543
	Redeemable common securities of subsidiary(f)	3		46				46				43				43
	(a)	Cash equivalents are composed of certificates of deposit, time deposits and other interest-bearing investments with original maturity dates of 90 days or less. Cash equivalents are recorded at cost, which approximates fair value.
	(b)	Time deposits are comprised of deposits with original maturities of more than 90 days but less than one year and instruments with original maturities of greater than one year, included in other current assets or other assets in the Consolidated Balance Sheet, as appropriate. Time deposits are recorded at cost, which approximates fair value.
	(c)	The note, monetization loan and redeemable preferred securities of subsidiaries are not traded in active markets. Accordingly, their fair values were calculated using a floating rate pricing model that compared the stated spread to the fair value spread to determine the price at which each of the financial instruments should trade. The model used the following inputs to calculate fair values: face value, current LIBOR rate, unobservable fair value credit spread, stated spread, maturity date and interest or dividend payment dates. See Note 8 for additional information.
	(d)	Short-term debt is comprised of U.S. commercial paper and/or other similar short-term debt issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value.
	(e)	Long-term debt includes the current portion of these debt instruments and excludes the monetization loan. Fair values were estimated based on quoted prices for financial instruments for which all significant inputs were observable, either directly or indirectly.
	(f)	The fair value of the redeemable common securities of subsidiary was based on various inputs, including an independent third-party appraisal, adjusted for current market conditions.

Acquisitions_and_Intangible_As1

Acquisitions and Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'
Changes in the Carrying Amount of Goodwill	'
		Personal			Consumer			K-C			Health			Total
		Care			Tissue			Professional			Care
	Balance at December 31, 2011	$	769		$	694		$	443		$	1,434		$	3,340
	Currency and other	(5		)	1			(1		)	2			(3		)
	Balance at December 31, 2012	764			695			442			1,436			3,337
	Acquisitions	6			—			—			3			9
	Currency and other	(86		)	(54		)	(18		)	(7		)	(165		)
	Balance at December 31, 2013	$	684		$	641		$	424		$	1,432		$	3,181
Other Intangible Assets	'
		2013						2012
		Gross			Accumulated			Gross			Accumulated
		Carrying			Amortization			Carrying			Amortization
		Amount						Amount
	Trademarks	$	252		$	163		$	253		$	156
	Patents and developed technologies	201			85			158			64
	Other	93			62			105			61
	Total	$	546		$	310		$	516		$	281

Debt_Tables

Debt (Tables)	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Long-term Debt	'
		Weighted-	Maturities	December 31
		Average
		Interest
		Rate		2013		2012
	Notes and debentures	5.20%	2014 - 2043	$	5,163	$	4,857
	Dealer remarketable securities	4.20%	2014 - 2016	200		200
	Industrial development revenue bonds	0.20%	2015 - 2034	261		261
	Bank loans and other financings in various currencies	5.60%	2014 - 2025	74		508
	Total long-term debt			5,698		5,826
	Less current portion			312		756
	Long-term portion			$	5,386	$	5,070

StockBased_Compensation_Tables

Stock-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2013
Share-based Compensation [Abstract]	'
Schedule of Assumptions Used to Estimate Weighted-Average Fair Value of Options Granted	'
		Year Ended December 31
		2013		2012			2011
	Dividend yield	3.7	%	4.5	%		5	%
	Volatility	15.4	%	12.86	%		12.54	%
	Risk-free interest rate	0.87	%	1.08	%		2.26	%
	Expected life—years	5.1		5.8			6.3
Schedule of Unrecognized Compensation Costs and Amortization Periods	'
		December 31, 2013			Weighted-
					Average
					Service
					Years
	Nonvested stock options	$	8		1
	Restricted shares and time-vested restricted share units	9			1.3
	Nonvested performance-based restricted share units	58			1.4
Schedule of Stock-Based Compensation Activity	'
	Stock Options	Shares		Weighted-				Weighted-		Aggregate
		(in thousands)		Average				Average		Intrinsic
				Exercise				Remaining		Value
				Price				Contractual
								Term
	Outstanding at January 1, 2013	9,268		$	65.38
	Granted	1,851		103.29
	Exercised	(3,661	)	63.13
	Forfeited or expired	(235	)	79.8
	Outstanding at December 31, 2013	7,223		75.77				6.6		$	207
	Exercisable at December 31, 2013	3,727		63.75				4.7		$	152
Schedule of Effect of Exercises of Stock Options	'
		Year Ended December 31
		2013			2012				2011
	Cash received	$	232		$	565			$	435
	Income tax benefit received	44			49				13
	Intrinsic value	138			161				69
Schedule of Other Stock-Based Awards Activity	'
		Time-Vested						Performance-Based
		Restricted Share						Restricted Share
		Units						Units
	Other Stock-Based Awards	Shares		Weighted-				Shares			Weighted-
		(in thousands)		Average				(in thousands)			Average
				Grant-Date							Grant-Date
				Fair Value							Fair Value
	Nonvested at January 1, 2013	324		$	75.24			2,187			$	67.41
	Granted	75		89.29				713			100.42
	Vested	(117	)	70.39				(294	)		62.72
	Forfeited	(25	)	76.52				(523	)		64.75
	Nonvested at December 31, 2013	257		81.38				2,083			79.98

Employee_Postretirement_Benefi1

Employee Postretirement Benefits (Tables)	12 Months Ended
	Dec. 31, 2013
Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]	'
Benefit Cost Information or Defined Benefit Plan and Other Postretirement Benefit Plan	'
		Pension Benefits								Other Benefits
		Year Ended December 31
		2013				2012				2013			2012
	Change in Benefit Obligation
	Benefit obligation at beginning of year	$	6,590			$	5,920			$	824		$	788
	Service cost	53				45				17			15
	Interest cost	257				279				32			36
	Actuarial loss (gain)	(422		)		854				(60		)	37
	Currency and other	47				79				—			3
	Benefit payments from plans	(343		)		(478		)		—			—
	Direct benefit payments	(13		)		(14		)		(52		)	(55		)
	Curtailment and settlements	(5		)		(95		)		—			—
	Benefit obligation at end of year	6,164				6,590				761			824
	Change in Plan Assets
	Fair value of plan assets at beginning of year	5,375				5,214				—			—
	Actual return on plan assets	268				556				—			—
	Employer contributions	220				110				—			—
	Currency and other	47				60				—			—
	Benefit payments	(343		)		(478		)		—			—
	Settlements	—				(87		)		—			—
	Fair value of plan assets at end of year	5,567				5,375				—			—
	Funded Status	$	(597	)		$	(1,215	)		$	(761	)	$	(824	)
	Amounts Recognized in the Balance Sheet
	Noncurrent asset—prepaid benefit cost	$	9			$	8			$	—		$	—
	Current liability—accrued benefit cost	(12		)		(12		)		(56		)	(56		)
	Noncurrent liability—accrued benefit cost	(594		)		(1,211		)		(705		)	(768		)
	Net amount recognized	$	(597	)		$	(1,215	)		$	(761	)	$	(824	)
Principal Plans and all Other Pension Plans	'
		Principal Plans								All Other							Total
										Pension Plans
		Year Ended December 31
		2013				2012				2013			2012				2013			2012
	Projected benefit obligation (“PBO”)	$	5,640			$	6,071			$	524		$	519			$	6,164		$	6,590
	Accumulated benefit obligation (“ABO”)	5,555				6,049				439			420				5,994			6,469
	Fair value of plan assets	5,205				5,063				362			312				5,567			5,375
Pension Plans with an ABO in Excess of Plan Assets	'
		December 31
		2013				2012
	PBO	$	5,722			$	6,558
	ABO	5,622				6,440
	Fair value of plan assets	5,163				5,335
Components of Net Periodic Benefit Cost	'
		Pension Benefits											Other Benefits
		Year Ended December 31
		2013				2012				2011			2013				2012			2011
	Service cost	$	53			$	45			$	57		$	17			$	15		$	14
	Interest cost	257				279				307			32				36			41
	Expected return on plan assets(a)	(331		)		(329		)		(345		)	—				—			—
	Recognized net actuarial loss	120				111				94			3				1			—
	Curtailment and settlements	(31		)		20				—			—				—			—
	Other	1				(4		)		6			(2		)		(1		)	1
	Net periodic benefit cost	$	69			$	122			$	119		$	50			$	51		$	56
	(a)	The expected return on plan assets is determined by multiplying the fair value of plan assets at the remeasurement date, typically the prior year-end, and adjusted for estimated current year cash benefit payments and contributions, by the expected long-term rate of return.
Weighted-Average Assumptions Used to Determine Net Cost	'
		Pension Benefits									Other Benefits
		2013			2012			2011			2013		2012			2011
	Discount rate	4.04	%		4.87	%		5.51	%		3.97	%	4.7	%		5.44	%
	Expected long-term return on plan assets	6.26	%		6.49	%		7.14	%		—		—			—
	Rate of compensation increase	2.73	%		2.91	%		4.05	%		—		—			—
Weighted-Average Assumptions Used to Determine Benefit Obligations	'
		Pension Benefits						Other Benefits
		2013			2012			2013			2012
	Discount rate	4.66	%		4.04	%		4.97	%		3.97	%
	Rate of compensation increase	2.67	%		2.73	%		—			—
Pension Plan Assets of the Principal Plans Measured at Fair Value	'
		Fair Value Measurements at December 31, 2013
		Total				Quoted Prices				Significant			Significant Unobservable Inputs (Level 3)
						in Active				Observable
						Markets for				Inputs
						Identical Assets				(Level 2)
						(Level 1)
	Cash and Cash Equivalents
	Held directly	$	33			$	33			$	—		$	—
	Held through mutual and pooled funds	173				34				139			—
	Fixed Income
	Held directly
	U.S. government and municipals	211				71				140			—
	U.S. corporate debt	1,654				—				1,654			—
	U.S. securitized fixed income	8				—				8			—
	Held through mutual and pooled funds
	U.S. corporate debt	186				—				186			—
	International bonds	1,089				—				1,089			—
	Multi-sector	2				2				—			—
	Equity
	Held directly
	U.S. equity	1				1				—			—
	Held through mutual and pooled funds
	U.S. equity	4				4				—			—
	Non-U.S. equity	123				1				122			—
	Global equity	1,691				—				1,691			—
	Insurance Contract	30				—				—			30
	Total Plan Assets	$	5,205			$	146			$	5,029		$	30
		Fair Value Measurements at December 31, 2012
		Total				Quoted Prices				Significant			Significant Unobservable Inputs (Level 3)
						in Active				Observable
						Markets for				Inputs
						Identical Assets				(Level 2)
						(Level 1)
	Cash and Cash Equivalents
	Held directly	$	23			$	23			$	—		$	—
	Held through mutual and pooled funds	143				—				143			—
	Fixed Income
	Held directly
	U.S. government and municipals	132				31				101			—
	U.S. corporate debt	1,112				—				1,112			—
	U.S. securitized fixed income	3				—				3			—
	Held through mutual and pooled funds
	U.S. government and municipals	490				—				490			—
	U.S. corporate debt	199				—				199			—
	International bonds	920				—				920			—
	Multi-sector	2				2				—			—
	Equity
	Held directly
	International equity	143				143				—			—
	Held through mutual and pooled funds
	U.S. equity	678				3				675			—
	Non-U.S. equity	925				1				924			—
	Global equity	293				—				293			—
	Total Plan Assets	$	5,063			$	203			$	4,860		$	—
Estimated Future Benefit Payments	'
		Pension Benefits				Other Benefits
	2014	$	369			$	57
	2015	374				59
	2016	374				60
	2017	382				61
	2018	386				63
	2019-2023	2,005				326
Defined Contribution Pension Plans	'
		2013				2012				2011
	U.S.	$	90			$	82			$	77
	Outside the U.S.	27				26				36
	Total	$	117			$	108			$	113

Accumulated_Other_Comprehensiv1

Accumulated Other Comprehensive Income (Tables)	12 Months Ended
	Dec. 31, 2013
Equity [Abstract]	'
Components of AOCI attributable to Kimberly-Clark	'
	The changes in the components of AOCI attributable to Kimberly-Clark, net of tax, are as follows:
			Unrealized Translation				Defined Benefit Pension Plans				Other Postretirement Benefit Plans				Cash Flow Hedges and Other
	Balance as of December 31, 2011		$	(221	)		$	(1,578	)		$	(31	)		$	(36	)
	Other comprehensive income (loss) before reclassifications		195				(407		)		(20		)		(13		)
	(Income) loss reclassified from AOCI		—				57			(a)	(2		)	(a)	(3		)
	Net current period other comprehensive income (loss)		195				(350		)		(22		)		(16		)
	Balance as of December 31, 2012		(26		)		(1,928		)		(53		)		(52		)
	Other comprehensive income (loss) before reclassifications		(499		)		218				36				24
	(Income) loss reclassified from AOCI		—				42			(a)	2			(a)	(6		)
	Net current period other comprehensive income (loss)		(499		)		260				38				18
	Balance as of December 31, 2013		$	(525	)		$	(1,668	)		$	(15	)		$	(34	)
	(a)	Included in computation of net periodic pension and postretirement benefits costs (see Note 10)
Change in Components of Accumulated Other Comprehensive Income (Loss)	'
		Year Ended December 31
		2013				2012				2011
	Unrealized translation	$	(495	)		$	204			$	(243	)
	Tax effect	(4		)		(9		)		7
		(499		)		195				(236		)
	Defined benefit pension plans
	Unrecognized net actuarial loss and transition amount
	Funded status recognition	356				(588		)		(396		)
	Amortization included in net periodic benefit cost	120				90				94
	Currency and other	(8		)		(20		)		(2		)
		468				(518		)		(304		)
	Unrecognized prior service cost/credit
	Funded status recognition	—				—				74
	Amortization included in net periodic benefit cost	(31		)		—				3
	Currency and other	(1		)		3				(4		)
		(32		)		3				73
	Tax effect	(176		)		165				99
		260				(350		)		(132		)
	Other postretirement benefit plans
	Unrecognized net actuarial loss and transition amount
	Funded status recognition	62				(31		)		(31		)
	Amortization included in net periodic benefit cost	3				(1		)		—
		65				(32		)		(31		)
	Unrecognized prior service cost/credit
	Funded status recognition	(3		)		—				31
	Amortization included in net periodic benefit cost	—				(2		)		1
		(3		)		(2		)		32
	Tax effect	(24		)		12				(2		)
		38				(22		)		(1		)
	Cash flow hedges and other
	Recognition of effective portion of hedges	37				(20		)		(81		)
	Amortization included in net income	(10		)		—				39
	Currency and other	4				(1		)		(13		)
		31				(21		)		(55		)
	Tax effect	(13		)		5				24
		18				(16		)		(31		)
	Change in AOCI	$	(183	)		$	(193	)		$	(400	)

Leases_and_Commitments_Tables

Leases and Commitments (Tables)	12 Months Ended
	Dec. 31, 2013
Leases and Commitments	'
Future Minimum Obligations under Operating Leases	'
		Year Ending December 31
	2014	$	189
	2015	155
	2016	124
	2017	113
	2018	76
	Thereafter	107
	Future minimum obligations	$	764

Objectives_and_Strategies_for_1

Objectives and Strategies for Using Derivatives (Tables)	12 Months Ended
	Dec. 31, 2013
Objectives and Strategies for Using Derivatives	'
Schedule of Fair Value of all Derivative Instruments	'
		Assets				Liabilities
		2013		2012		2013		2012
	Foreign currency exchange contracts	$	34	$	52	$	49	$	17
	Interest rate contracts	22		7		—		43
	Commodity price contracts	6		2		—		3
	Total	$	62	$	61	$	49	$	63

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2013
Income Tax Expense (Benefit) [Abstract]	'
Analysis of the Provision for Income Taxes	'
		Year Ended December 31
		2013				2012				2011
	Current income taxes
	United States	$	350			$	182			$	43
	State	110				30				32
	Other countries	318				332				311
	Total	778				544				386
	Deferred income taxes
	United States	85				204				254
	State	14				34				29
	Other countries	52				(14		)		(9		)
	Total	151				224				274
	Total provision for income taxes	$	929			$	768			$	660
Income before Income Taxes	'
		Year Ended December 31
		2013				2012				2011
	United States	$	1,764			$	1,415			$	1,317
	Other countries	1,181				1,005				866
	Total income before income taxes	$	2,945			$	2,420			$	2,183
Deferred Income Tax assets (Liabilities)	'
			31-Dec
			2013				2012
	Deferred tax assets
	Pension and other postretirement benefits		$	728			$	972
	Tax credits and loss carryforwards		604				729
	Property, plant and equipment, net		104				110
	Other		516				492
			1,952				2,303
	Valuation allowance		(197		)		(215		)
	Total deferred assets		1,755				2,088
	Deferred tax liabilities
	Pension and other postretirement benefits		259				269
	Property, plant and equipment, net		1,244				1,228
	Installment sales		6				120
	Investments in subsidiaries		205				108
	Other		390				385
	Total deferred tax liabilities		2,104				2,110
	Net deferred tax assets (liabilities)		$	(349	)		$	(22	)
Reconciliation of Income Tax Provision	'
		Year Ended December 31
		2013			2012			2011
	U.S. statutory rate applied to income before income taxes	35	%		35	%		35	%
	Rate of state income taxes, net of federal tax benefit	2.7			1.7			1.8
	Statutory rates other than U.S. statutory rate	(2.9	)		(2.8	)		(2.3	)
	Other - net(a)	(3.3	)		(2.2	)		(4.3	)
	Effective income tax rate	31.5	%		31.7	%		30.2	%
Unrecognized Income Tax Benefits	'
		2013				2012				2011
	Balance at January 1	$	435			$	558			$	568
	Gross increases for tax positions of prior years	73				30				17
	Gross decreases for tax positions of prior years	(31		)		(104		)		(60		)
	Gross increases for tax positions of the current year	37				52				55
	Settlements	(35		)		(100		)		(15		)
	Other	(6		)		(1		)		(7		)
	Balance at December 31	$	473			$	435			$	558
Summary of Income Tax Examinations	'
	Jurisdiction	Years
	United States	2010 to 2013
	United Kingdom	2012 to 2013
	Canada	2010 to 2013
	Korea	2008 to 2013
	Australia	2009 to 2013

Earnings_Per_Share_Tables

Earnings Per Share (Tables)	12 Months Ended
	Dec. 31, 2013
Earnings Per Share [Abstract]	'
Average Common Shares Outstanding Basic and Diluted	'
	(Millions of shares)		2013	2012		2011
	Average shares outstanding		384	393		395.4
	Participating securities		—	—		0.3
	Basic		384	393		395.7
	Dilutive effect of stock options and restricted share unit awards		3.3	3.1		2.9
	Diluted		387.3	396.1		398.6
Options Outstanding not Included in Computation of Diluted EPS	'
		2013		2012			2011
	Average number of share equivalents (millions)	1.1		1.1			3.6
	Weighted-average exercise price	$	103.29	$	78.54		$	71.49
	Options outstanding at year-end (millions)	1.8		1.7			3

Business_Segment_and_Geographi

Business Segment and Geographic Data Information (Tables)	12 Months Ended
	Dec. 31, 2013
Description of Business Segments	'
Informatiion Concerning Consolidated Operations by Business Segment	'
		Personal			Consumer			K-C			Health		Corporate				Consolidated
		Care			Tissue			Professional			Care		& Other				Total
	Net Sales(a)
	2013	$	9,536		$	6,637		$	3,323		$	1,618	$	38			$	21,152
	2012	9,576			6,527			3,283			1,622		55				21,063
	2011	9,128			6,770			3,294			1,606		48				20,846
	Operating Profit(b)
	2013	1,698			988			608			230		(316		)	(c)	3,208
	2012	1,660			887			545			229		(635		)	(c)	2,686
	2011	1,526			775			487			219		(565		)	(c)	2,442
	Depreciation and Amortization
	2013	332			318			138			71		4				863
	2012	315			331			141			59		11				857
	2011	296			541			187			55		12				1,091
	Assets
	2013	6,623			5,483			2,431			2,370		2,012				18,919
	2012	7,014			5,531			2,739			2,531		2,058				19,873
	2011	6,582			5,685			2,783			2,529		1,794				19,373
	Capital Spending
	2013	461			328			118			44		2				953
	2012	551			352			116			42		32				1,093
	2011	543			255			114			53		3				968
	(a)	Net sales in the United States to third parties totaled $9,783, $9,720 and $9,715 in 2013, 2012 and 2011, respectively.
	(b)	Segment operating profit excludes other (income) and expense, net and income and expenses not associated with the business segments.
	(c)	Corporate & Other includes the following charges:
		Year Ended December 31
		2013			2012								2011
		European Strategic			European Strategic			Pulp and Tissue			Total		Pulp and Tissue
		Changes			Changes			Restructuring Actions					Restructuring Actions
	Personal Care	$	36		$	213		$	—		$	213	$	—
	Consumer Tissue	27			66			125			191		357
	K-C Professional	13			20			9			29		56
	Other (income) and expense, net	5			—			1			1		2
	Total	$	81		$	299		$	135		$	434	$	415
	In addition, Corporate and Other for the year ended December 31, 2013 includes a pre-tax charge of $36 related to the devaluation of the Venezuelan bolivar and for the year ended December 31, 2011 includes a non-deductible business tax charge of $32 related to a law change in Colombia.
Sales of Principal Products	'
	(Billions of dollars)		2013			2012			2011
	Consumer tissue products		$	6.6		$	6.5		$	6.7
	Baby and child care products		7			7.1			6.8
	Away-from-home professional products		3.3			3.3			3.3
	All other		4.3			4.2			4
	Consolidated		$	21.2		$	21.1		$	20.8

Supplemental_Data_Tables

Supplemental Data (Tables)	12 Months Ended
	Dec. 31, 2013
Supplemental Income Statement Data	'
		Year Ended December 31
		2013			2012			2011
	Advertising expense	$	777		$	810		$	686
	Research expense	360			356			316
Equity Method Investments Data	'
		Net			Gross			Operating			Net			Corporation's
		Sales			Profit			Profit			Income			Share of Net
														Income
	2013	$	2,638		$	950		$	642		$	426		$	205
	2012	2,514			864			567			368			176
	2011	2,446			796			514			335			161
		Current			Non-			Current			Non-			Stockholders'
		Assets			Current			Liabilities			Current			Equity
					Assets						Liabilities
	2013	$	1,197		$	1,124		$	847		$	845		$	629
	2012	1,054			1,068			712			837			573
	2011	1,000			906			491			872			543
Supplemental Cash Flow Data	'
	Summary of Cash Flow Effects of Decrease (Increase) in Operating Working Capital	Year Ended December 31
		2013			2012			2011
	Accounts receivable	$	4		$	(38	)	$	(169	)
	Inventories	100			9			9
	Prepaid expenses	7			1			(19		)
	Trade accounts payable	128			45			161
	Accrued expenses	(177		)	133			(91		)
	Accrued income taxes	(90		)	13			(107		)
	Derivatives	5			(86		)	33
	Currency	(135		)	42			(79		)
	Total	$	(158	)	$	119		$	(262	)
		Year Ended December 31
	Other Cash Flow Data	2013			2012			2011
	Interest paid	$	307		$	299		$	273
	Income taxes paid	776			451			463
Accounts Receivable, Net [Member]	'
Supplemental Balance Sheet Data	'
		December 31
	Summary of Accounts Receivable, Net	2013			2012
	From customers	$	2,345		$	2,346
	Other	271			376
	Less allowance for doubtful accounts and sales discounts	(71		)	(80		)
	Total	$	2,545		$	2,642
Inventories [Member]	'
Supplemental Balance Sheet Data	'
		December 31
		2013									2012
	Summary of Inventories by Major Class	LIFO			Non-			Total			LIFO			Non-		Total
					LIFO									LIFO
	At the lower of cost, determined on the FIFO or weighted-average cost methods, or market
	Raw materials	$	143		$	319		$	462		$	148		$	346	$	494
	Work in process	189			97			286			194			135		329
	Finished goods	648			753			1,401			656			786		1,442
	Supplies and other	—			326			326			—			314		314
		980			1,495			2,475			998			1,581		2,579
	Excess of FIFO or weighted-average cost over LIFO cost	(242		)	—			(242		)	(231		)	—		(231		)
	Total	$	738		$	1,495		$	2,233		$	767		$	1,581	$	2,348
Property, Plant and Equipment, Net [Member]	'
Supplemental Balance Sheet Data	'
		December 31
	Summary of Property, Plant and Equipment, Net	2013			2012
	Land	$	196		$	199
	Buildings	2,776			2,732
	Machinery and equipment	14,193			13,993
	Construction in progress	515			732
		17,680			17,656
	Less accumulated depreciation	(9,732		)	(9,561		)
	Total	$	7,948		$	8,095
Accrued Liabilities [Member]	'
Supplemental Balance Sheet Data	'
		December 31
	Summary of Accrued Expenses	2013			2012
	Accrued advertising and promotion	$	355		$	372
	Accrued salaries and wages	471			456
	Accrued rebates	358			340
	Accrued taxes - income and other	336			336
	Other	540			740
	Total	$	2,060		$	2,244
Other Cash Flow Data and Interest Expense [Member]	'
Supplemental Cash Flow Data	'
		Year Ended December 31
	Other Cash Flow Data	2013			2012			2011
	Interest paid	$	307		$	299		$	273
	Income taxes paid	776			451			463

Valuation_and_Qualifying_Accou1

Valuation and Qualifying Accounts (Tables)	12 Months Ended
	Dec. 31, 2013
Valuation and Qualifying Accounts	'
Schedule of Valuation and Qualifying Accounts [Table Text Block]	'
	KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES
	SCHEDULE II
	VALUATION AND QUALIFYING ACCOUNTS
	FOR THE YEARS ENDED DECEMBER 31, 2013, 2012 AND 2011
	(Millions of dollars)
	Description	Balance at		Additions						Deductions
		Beginning
		of Period		Charged to			Charged to			Write-Offs and				Balance
				Costs and			Other			Reclassifications				at End of
				Expenses			Accounts(a)							Period
	December 31, 2013
	Allowances deducted from assets to which they apply
	Allowance for doubtful accounts	$	60	$	—		$	(4	)	$	5		(b)	$	51
	Allowances for sales discounts	20		275			(1		)	274			(c)	20
	December 31, 2012
	Allowances deducted from assets to which they apply
	Allowance for doubtful accounts	$	57	$	9		$	—		$	6		(b)	$	60
	Allowances for sales discounts	21		280			—			281			(c)	20
	December 31, 2011
	Allowances deducted from assets to which they apply
	Allowance for doubtful accounts	$	62	$	5		$	(5	)	$	5		(b)	$	57
	Allowances for sales discounts	18		275			—			272			(c)	21
	(a)	Includes bad debt recoveries and the effects of changes in foreign currency exchange rates.
	(b)	Primarily uncollectible receivables written off.
	(c)	Sales discounts allowed.
				Additions
	Description	Balance at		Charged to			Charged to			Deductions(a)				Balance
		Beginning		Costs and			Other							at End
		of Period		Expenses			Accounts							of  Period
	December 31, 2013
	Deferred taxes
	Valuation allowance	$	215	$	(11	)	$	—		$	7			$	197
	December 31, 2012
	Deferred taxes
	Valuation allowance	$	229	$	(18	)	$	—		$	(4	)		$	215
	December 31, 2011
	Deferred taxes
	Valuation allowance	$	287	$	(51	)	$	—		$	7			$	229
	(a)	Represents the net currency effects of translating valuation allowances at current rates of exchange.

Accounting_Policies_Narrative_

Accounting Policies (Narrative) (Details) (USD $)	12 Months Ended			33 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Feb. 01, 2013
Minimum ownership percentage to exercise significant influence	20.00%	'	'	'
K-C Venezuela [Member]	'	'	'	'
Central Bank System Rate	6.3	'	'	5.4
Charge for Devaluation Under Highly Inflationary Accounting (after tax)	$26	'	'	'
Charge for Devaluation Under Highly Inflationary Accounting	36	'	'	'
Bolivar Denominated Monetary Asset Net	309	'	'	'
Net Investment Foreign Operations	$445	'	'	'
Portion Of Consolidated Net Sales Earned By Affiliate Percent	2.00%	2.00%	1.00%	'
Trademarks | Minimum [Member]	'	'	'	'
Finite-Lived Intangible Assets, Useful Life	'2 years	'	'	'
Trademarks | Maximum [Member]	'	'	'	'
Finite-Lived Intangible Assets, Useful Life	'30 years	'	'	'
Patents and developed technologies | Minimum [Member]	'	'	'	'
Finite-Lived Intangible Assets, Useful Life	'5 years	'	'	'
Patents and developed technologies | Maximum [Member]	'	'	'	'
Finite-Lived Intangible Assets, Useful Life	'17 years	'	'	'
Other | Minimum [Member]	'	'	'	'
Finite-Lived Intangible Assets, Useful Life	'5 years	'	'	'
Other | Maximum [Member]	'	'	'	'
Finite-Lived Intangible Assets, Useful Life	'16 years	'	'	'
Building [Member]	'	'	'	'
Estimated useful life	'40 years	'	'	'
Machinery and Equipment [Member] | Minimum [Member]	'	'	'	'
Estimated useful life	'16 years	'	'	'
Machinery and Equipment [Member] | Maximum [Member]	'	'	'	'
Estimated useful life	'20 years	'	'	'
Software [Member]	'	'	'	'
Estimated useful life	'5 years	'	'	'

Proposed_Spinoff_of_Health_Car1

Proposed Spinoff of Health Care Business Proposed Spinoff of Health Care Business Narrative (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Restructuring Cost and Reserve	'		'		'
Net Sales	$21,152	[1]	$21,063	[1]	$20,846	[1]
Health Care Spin-off [Member]	'		'		'
Restructuring Cost and Reserve	'		'		'
Net Sales	$1,600		'		'
[1]	Net sales in the United States to third parties totaled $9,783, $9,720 and $9,715 in 2013, 2012 and 2011, respectively.

European_Strategic_Changes_Eur1

European Strategic Changes European Strategic Changes (Narrative) (Details) (European Strategic Changes [Member])	12 Months Ended
	Dec. 31, 2013
European Strategic Changes [Member]	'
Restructuring Cost and Reserve	'
Restructuring Activities for Manufacturing Facilities	5

European_Strategic_Changes_Eur2

European Strategic Changes European Strategic Changes - Charges Incurred (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Restructuring Cost and Reserve	'	'
Charges for workforce reductions and other exit costs	'	$434
European Strategic Changes [Member]	'	'
Restructuring Cost and Reserve	'	'
Net charges	66	242
European Strategic Changes [Member] | Cost of Sales [Member]	'	'
Restructuring Cost and Reserve	'	'
Charges for workforce reductions and other exit costs	54	250
European Strategic Changes [Member] | Charges for workforce reductions and other exit costs included in marketing, research and general expenses and other (income) and expense, net	'	'
Restructuring Cost and Reserve	'	'
Charges for workforce reductions and other exit costs	27	49
European Strategic Changes [Member] | Provision for income taxes	'	'
Restructuring Cost and Reserve	'	'
Charges for workforce reductions and other exit costs	-15	-57
European Strategic Changes [Member] | Asset impairments | Cost of Sales [Member]	'	'
Restructuring Cost and Reserve	'	'
Charges for workforce reductions and other exit costs	22	147
European Strategic Changes [Member] | Charges for workforce reductions | Cost of Sales [Member]	'	'
Restructuring Cost and Reserve	'	'
Charges for workforce reductions and other exit costs	10	77
European Strategic Changes [Member] | Asset write-offs | Cost of Sales [Member]	'	'
Restructuring Cost and Reserve	'	'
Charges for workforce reductions and other exit costs	13	10
European Strategic Changes [Member] | Incremental depreciation | Cost of Sales [Member]	'	'
Restructuring Cost and Reserve	'	'
Charges for workforce reductions and other exit costs	18	8
European Strategic Changes [Member] | Benefit from pension curtailment | Cost of Sales [Member]	'	'
Restructuring Cost and Reserve	'	'
Charges for workforce reductions and other exit costs	-31	0
European Strategic Changes [Member] | Other exit costs | Cost of Sales [Member]	'	'
Restructuring Cost and Reserve	'	'
Charges for workforce reductions and other exit costs	$22	$8

European_Strategic_Changes_Eur3

European Strategic Changes European Strategic Changes - Reconciliaton to Accrued Expenses (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Accrued Expense Roll Forward	'	'
Charges for workforce reductions and other exit costs	'	$434
European Strategic Changes [Member]	'	'
Accrued Expense Roll Forward	'	'
Accrued expenses - January 1	133	0
Cash payments	-156	-4
Currency and other	-9	3
Accrued expenses - December 31	37	133
European Strategic Changes [Member] | Cash charges [Member]	'	'
Accrued Expense Roll Forward	'	'
Charges for workforce reductions and other exit costs	$69	$134

Pulp_And_Tissue_Restructuring_

Pulp And Tissue Restructuring Pulp and Tissue Narrative (Details) (USD $)

12 Months Ended

In Millions, unless otherwise specified

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2011

Pulp And Tissue Restructuring [Member]

Pulp And Tissue Restructuring [Member]

Pulp And Tissue Restructuring [Member]

Pulp And Tissue Restructuring [Member]

Pulp And Tissue Restructuring [Member]

Pulp And Tissue Restructuring [Member]

Pulp And Tissue Restructuring [Member]

Pulp And Tissue Restructuring [Member]

Pulp And Tissue Restructuring [Member]

Pulp And Tissue Restructuring [Member]

Pulp And Tissue Restructuring [Member]

Pulp And Tissue Restructuring [Member]

Pulp And Tissue Restructuring [Member]

Pulp And Tissue Restructuring [Member]

Pulp And Tissue Restructuring [Member]

United States

United States

Australia

Australia

Other Geographic Areas [Member]

Other Geographic Areas [Member]

Cost of Sales [Member]

Cost of Sales [Member]

Charges for workforce reductions and other included in marketing, research and general expenses

Charges for workforce reductions and other included in marketing, research and general expenses

Other (Income) And Expense, Net [Member]

Other (Income) And Expense, Net [Member]

Provision for income taxes

Provision for income taxes

Restructuring Cost and Reserve

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Restructuring Activities for Manufacturing Facilities

'

7

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Charges for workforce reductions and other exit costs

$434

'

$97

$204

$35

$133

$3

$78

$128

$407

$6

$6

$1

$2

$49

$126

Fair_Value_Information_Fair_Va

Fair Value Information (Fair Value Assets and Liabilities Measured On A Recurring Basis) (Details) (Fair Value, Measurements, Recurring [Member], USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'	'
Company-owned life insurance (COLI)	$55	$49
Available-for-sale securities	22	17
Derivatives	62	61
Total	139	127
Derivatives	49	63
Fair Value, Inputs, Level 1 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'	'
Company-owned life insurance (COLI)	0	0
Available-for-sale securities	22	17
Derivatives	0	0
Total	22	17
Derivatives	0	0
Fair Value, Inputs, Level 2 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'	'
Company-owned life insurance (COLI)	55	49
Available-for-sale securities	0	0
Derivatives	62	61
Total	117	110
Derivatives	49	63
Fair Value, Inputs, Level 3 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'	'
Company-owned life insurance (COLI)	0	0
Available-for-sale securities	0	0
Derivatives	0	0
Total	0	0
Derivatives	$0	$0

Fair_Value_Information_Fair_Va1

Fair Value Information (Fair Value of Financial Instruments) (Details) (USD $)	Dec. 31, 2013		Dec. 31, 2012
In Millions, unless otherwise specified
Fair Value, Balance Sheet Grouping, Financial Statement Captions	'		'
Redeemable preferred securities of subsidiaries(c)	($26)		'
Fair Value, Inputs, Level 1 [Member] | Carrying (Reported) Amount, Fair Value Disclosure [Member]	'		'
Fair Value, Balance Sheet Grouping, Financial Statement Captions	'		'
Cash and cash equivalents(a)	1,054	[1]	1,106	[1]
Time deposits(b)	222	[2]	224	[2]
Fair Value, Inputs, Level 1 [Member] | Estimate of Fair Value, Fair Value Disclosure [Member]	'		'
Fair Value, Balance Sheet Grouping, Financial Statement Captions	'		'
Cash and cash equivalents(a)	1,054	[1]	1,106	[1]
Time deposits(b)	222	[2]	224	[2]
Fair Value, Inputs, Level 2 [Member] | Carrying (Reported) Amount, Fair Value Disclosure [Member]	'		'
Fair Value, Balance Sheet Grouping, Financial Statement Captions	'		'
Short-term debt(d)	63	[3]	359	[3]
Long-term debt(e)	5,698	[4]	5,429	[4]
Fair Value, Inputs, Level 2 [Member] | Estimate of Fair Value, Fair Value Disclosure [Member]	'		'
Fair Value, Balance Sheet Grouping, Financial Statement Captions	'		'
Short-term debt(d)	63	[3]	359	[3]
Long-term debt(e)	6,271	[4]	6,527	[4]
Fair Value, Inputs, Level 3 [Member] | Carrying (Reported) Amount, Fair Value Disclosure [Member]	'		'
Fair Value, Balance Sheet Grouping, Financial Statement Captions	'		'
Note receivable(c)	16	[5]	395	[5]
Monetization loan(c)	0	[5]	397	[5]
Fair Value, Inputs, Level 3 [Member] | Estimate of Fair Value, Fair Value Disclosure [Member]	'		'
Fair Value, Balance Sheet Grouping, Financial Statement Captions	'		'
Note receivable(c)	16	[5]	392	[5]
Monetization loan(c)	0	[5]	400	[5]
Preferred securities [Member] | Fair Value, Inputs, Level 3 [Member] | Carrying (Reported) Amount, Fair Value Disclosure [Member]	'		'
Fair Value, Balance Sheet Grouping, Financial Statement Captions	'		'
Redeemable preferred securities of subsidiaries(c)	532	[5]	506	[5]
Preferred securities [Member] | Fair Value, Inputs, Level 3 [Member] | Estimate of Fair Value, Fair Value Disclosure [Member]	'		'
Fair Value, Balance Sheet Grouping, Financial Statement Captions	'		'
Redeemable preferred securities of subsidiaries(c)	552	[5]	543	[5]
common securities [Member] | Fair Value, Inputs, Level 3 [Member] | Carrying (Reported) Amount, Fair Value Disclosure [Member]	'		'
Fair Value, Balance Sheet Grouping, Financial Statement Captions	'		'
Redeemable preferred securities of subsidiaries(c)	46	[6]	43	[6]
common securities [Member] | Fair Value, Inputs, Level 3 [Member] | Estimate of Fair Value, Fair Value Disclosure [Member]	'		'
Fair Value, Balance Sheet Grouping, Financial Statement Captions	'		'
Redeemable preferred securities of subsidiaries(c)	$46	[6]	$43	[6]
[1]	Cash equivalents are composed of certificates of deposit, time deposits and other interest-bearing investments with original maturity dates of 90 days or less. Cash equivalents are recorded at cost, which approximates fair value.
[2]	Time deposits are comprised of deposits with original maturities of more than 90 days but less than one year and instruments with original maturities of greater than one year, included in other current assets or other assets in the Consolidated Balance Sheet, as appropriate. Time deposits are recorded at cost, which approximates fair value.
[3]	Short-term debt is comprised of U.S. commercial paper and/or other similar short-term debt issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value.
[4]	Long-term debt includes the current portion of these debt instruments and excludes the monetization loan. Fair values were estimated based on quoted prices for financial instruments for which all significant inputs were observable, either directly or indirectly.
[5]	The note, monetization loan and redeemable preferred securities of subsidiaries are not traded in active markets. Accordingly, their fair values were calculated using a floating rate pricing model that compared the stated spread to the fair value spread to determine the price at which each of the financial instruments should trade. The model used the following inputs to calculate fair values: face value, current LIBOR rate, unobservable fair value credit spread, stated spread, maturity date and interest or dividend payment dates.
[6]	The fair value of the redeemable common securities of subsidiary was based on various inputs, including an independent third-party appraisal, adjusted for current market conditions.

Acquisitions_and_Intangible_As2

Acquisitions and Intangible Assets (Narrative) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Goodwill and Intangible Assets Disclosure [Abstract]	'	'	'
Indefinite-lived Intangible Assets	$7	$11	'
Amortization expense for intangible assets	39	29	24
Amortization expense, 2014	42	'	'
Amortization expense, 2015	34	'	'
Amortization expense, 2016	28	'	'
Amortization expense, 2017	23	'	'
Amortization expense, 2018	$19	'	'

Acquisitions_and_Intangible_As3

Acquisitions and Intangible Assets (Changes in the Carrying Amount of Goodwill) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Goodwill [Roll Forward]	'	'
Goodwill, Beginning Balance	$3,337	$3,340
Acquisitions	9	'
Currency and other	-165	-3
Goodwill, Ending Balance	3,181	3,337
Personal Care [Member]	'	'
Goodwill [Roll Forward]	'	'
Goodwill, Beginning Balance	764	769
Acquisitions	6	'
Currency and other	-86	-5
Goodwill, Ending Balance	684	764
Consumer Tissue [Member]	'	'
Goodwill [Roll Forward]	'	'
Goodwill, Beginning Balance	695	694
Acquisitions	0	'
Currency and other	-54	1
Goodwill, Ending Balance	641	695
K-C Professional and Other [Member]	'	'
Goodwill [Roll Forward]	'	'
Goodwill, Beginning Balance	442	443
Acquisitions	0	'
Currency and other	-18	-1
Goodwill, Ending Balance	424	442
Health Care [Member]	'	'
Goodwill [Roll Forward]	'	'
Goodwill, Beginning Balance	1,436	1,434
Acquisitions	3	'
Currency and other	-7	2
Goodwill, Ending Balance	$1,432	$1,436

Acquisitions_and_Intangible_As4

Acquisitions and Intangible Assets (Other Intangible Assets) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Indefinite-lived Intangible Assets	'	'
Gross Carrying Amount	$546	$516
Accumulated Amortization	310	281
Trademarks	'	'
Indefinite-lived Intangible Assets	'	'
Gross Carrying Amount	252	253
Accumulated Amortization	163	156
Patents and developed technologies	'	'
Indefinite-lived Intangible Assets	'	'
Gross Carrying Amount	201	158
Accumulated Amortization	85	64
Other	'	'
Indefinite-lived Intangible Assets	'	'
Gross Carrying Amount	93	105
Accumulated Amortization	$62	$61

Debt_LongTerm_Debt_Details

Debt (Long-Term Debt) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Total long-term debt	$5,698	$5,826
Less current portion	312	756
Long-term portion	5,386	5,070
Notes and debentures	'	'
Weighted- Average Interest Rate	5.19%	'
Maturities (start)	1-Jan-14	'
Maturities (end)	31-Dec-43	'
Total long-term debt	5,163	4,857
Dealer remarketable securities	'	'
Weighted- Average Interest Rate	4.17%	'
Maturities (start)	1-Jan-14	'
Maturities (end)	31-Dec-16	'
Total long-term debt	200	200
Industrial development revenue bonds	'	'
Weighted- Average Interest Rate	0.24%	'
Maturities (start)	1-Jan-14	'
Maturities (end)	31-Dec-34	'
Total long-term debt	261	261
Bank Loans And Other Financings In Various Currencies [Member]	'	'
Weighted- Average Interest Rate	5.62%	'
Maturities (start)	1-Jan-14	'
Maturities (end)	31-Dec-25	'
Total long-term debt	$74	$508

Debt_Narrative_Details

Debt (Narrative) (Details) (USD $)

Dec. 31, 2013

Dec. 31, 2013

Jun. 30, 2013

Dec. 31, 2013

Jun. 30, 2013

Dec. 31, 2013

Jun. 30, 2013

Dec. 31, 2013

Jun. 30, 2013

Dec. 31, 2013

Mar. 31, 2012

Dec. 31, 2012

Mar. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2006

In Millions, unless otherwise specified

Floating Rate Notes Due May 15, 2016 [Member]

Floating Rate Notes Due May 15, 2016 [Member]

2.4% Notes Due June 1, 2023 [Member]

2.4% Notes Due June 1, 2023 [Member]

3.7% Notes Due June 1, 2043 [Member]

3.7% Notes Due June 1, 2043 [Member]

5% Notes Due August 15, 2013 [Member]

5% Notes Due August 15, 2013 [Member]

2.4% Notes Due March 21, 2022 [Member]

2.4% Notes Due March 21, 2022 [Member]

5.625% Notes Due February 15, 2012 [Member]

5.625% Notes Due February 15, 2012 [Member]

3.875% Notes Due March 1, 2021 [Member]

5.30% Notes Due March 1, 2041 [Member]

Option to Increase Facility [Member]

Expiring 2016 [Member]

Expiring 2016 [Member]

Dealer remarketable securities

Dealer remarketable securities

Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months

$312

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long-term Debt, Maturities, Repayments of Principal in Year Two

353

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long-term Debt, Maturities, Repayments of Principal in Year Three

302

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long-term Debt, Maturities, Repayments of Principal in Year Four

962

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long-term Debt, Maturities, Repayments of Principal in Year Five

902

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Face amount of note

'

'

250

'

350

'

250

'

500

'

300

'

400

250

450

'

'

'

'

200

Interest rate of note

'

'

'

'

2.40%

'

3.70%

'

5.00%

2.40%

'

'

5.63%

3.88%

5.30%

'

'

'

'

'

Maturity date

'

15-May-16

'

1-Jun-23

'

1-Jun-43

'

15-Aug-13

'

1-Mar-22

'

15-Feb-12

'

1-Mar-21

1-Mar-41

'

'

'

31-Dec-16

'

Debt Instrument, Issuance Date

'

31-May-13

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Revolving credit facility

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$500

'

$1,500

'

'

Expiration date of revolving credit facility

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

31-Oct-16

'

'

'

Redeemable_Preferred_and_Commo1

Redeemable Preferred and Common Securities of Subsidiaries (Narratives) (Details) (USD $)	0 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Jul. 07, 2011	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Notes Receivable Face Amount	'	$397	'	'
Notes receivable, maturity date	'	'September 30, 2014	'	'7/7/2011
Loans Receivable, Description of Variable Rate Basis	'	'LIBOR	'	'
Loans Receivable, Basis Spread on Variable Rate	'	0.75%	'	'
Debt Instrument, Description of Variable Rate Basis	'	1.50%	'	'
Loans maturity date	'	31-Jan-14	'	'
Debt Instrument, Description of Variable Rate Basis	'	'LIBOR	'	'
Redeemable Preferred And Common Securities Of Subsidiaries Fair Value Disclosure	'	26	'	'
Net cash payments to restructure financing entity	'	24	'	'
Proceeds from Collection of Notes Receivable	220	0	0	220
Preferred securities	'	1,000	'	'
Preferred Stock, Redemption Date	'	1-Dec-14	'	'
Voting Rights Preferred Stock	'	96.00%	'	'
Issuance of voting preferred and common securities to K-C	'	500	'	'
Combined Voting Rights Of Preferred And Common Securities	'	4.00%	'	'
Percent of cash contributions loaned to K-C	'	98.00%	'	'
Return on redeemable preferred securities and noncontrolling interests and other	'	27	27	52
Preferred Securities Class A-1 [Member]	'	'	'	'
Preferred securities	'	500	'	'
Preferred Stock, Dividend Rate, Percentage	'	'	5.07%	'
Preferred Securities Class A-2 [Member]	'	'	'	'
Preferred securities	'	500	'	'
Preferred Stock, Dividend Rate, Percentage	'	'	5.42%	'
Monetization Loans [Member]	'	'	'	'
Loans Payable, Fair Value Disclosure	'	$397	'	'

StockBased_Compensation_Narrat

Stock-Based Compensation (Narrative) (Details) (USD $)	12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award	'	'	'
Shares of common stock available for grants	21.3	'	'
Recognition of stock-based compensation	$92	$67	$48
Deferred income tax benefits on stock-based compensation	35	20	15
Weighted-average fair value of options granted	$7.15	$3.25	$2.98
Excess tax benefits	50	50	15
Total fair value of restricted shares and restricted share units	$45	$101	$28
Stock Options [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award	'	'	'
Stock options term, years	10	'	'
Vesting percentage at the end of each of the first two 12 months period	30.00%	'	'
Vesting percentage at the end of third 12 months period	40.00%	'	'
Restricted Stock [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award	'	'	'
General vesting period	'3 years	'	'
Performance Shares [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award	'	'	'
Ultimately vested units range, minimum	0.00%	'	'
Ultimately vested units range, maximum	200.00%	'	'

StockBased_Compensation_Schedu

Stock-Based Compensation (Schedule of Assumptions Used to Estimate Weighted-Average Fair Value of Options Granted) (Details)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]	'	'	'
Dividend yield	3.70%	4.50%	5.00%
Volatility	15.40%	12.86%	12.54%
Risk-free interest rate	0.87%	1.08%	2.26%
Expected life—years	'5 years 1 month 6 days	'5 years 9 months 18 days	'6 years 3 months 18 days

StockBased_Compensation_Schedu1

Stock-Based Compensation (Schedule of Unrecognized Compensation Costs and Amortization Periods) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013
Nonvested stock options	'
Share-based Compensation Arrangement by Share-based Payment Award	'
Unrecognized compensation costs	$8
Weighted- Average Service Years	'1 year
Restricted shares and time-vested restricted share units	'
Share-based Compensation Arrangement by Share-based Payment Award	'
Unrecognized compensation costs	9
Weighted- Average Service Years	'1 year 3 months 18 days
Nonvested performance-based restricted share units	'
Share-based Compensation Arrangement by Share-based Payment Award	'
Unrecognized compensation costs	$58
Weighted- Average Service Years	'1 year 4 months 24 days

StockBased_Compensation_Schedu2

Stock-Based Compensation (Schedule of Stock-Based Compensation Activity) (Details) (USD $)	12 Months Ended
In Millions, except Share data in Thousands, unless otherwise specified	Dec. 31, 2013
Share-based Compensation [Abstract]	'
Outstanding at January 1, 2013	9,268
Granted	1,851
Exercised	-3,661
Forfeited or expired	-235
Outstanding at December 31, 2013	7,223
Exercisable at December 31, 2013	3,727
Outstanding at January 1, Weighted-Average Exercise Price	$65.38
Granted, Weighted-Average Exercise Price	$103.29
Exercised, Weighted-Average Exercise Price	$63.13
Forfeited or expired, Weighted-Average Exercise Price	$79.80
Outstanding at December 31, Weighted-Average Exercise Price	$75.77
Exercisable at December 31, Weighted-Average Exercise Price	$63.75
Outstanding at December 31, Weighted-Average Remaining Contractual Term	'6 years 7 months 6 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	'4 years 8 months 12 days
Outstanding at December 31, Aggregate Intrinsic Value	$207
Exercisable at December 31, Aggregate Intrinsic Value	$152

StockBased_Compensation_Schedu3

Stock-Based Compensation (Schedule of Effect of Exercises of Stock Options) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Share-based Compensation [Abstract]	'	'	'
Cash received	$232	$565	$435
Income tax benefit received	44	49	13
Intrinsic value	$138	$161	$69

StockBased_Compensation_Schedu4

Stock-Based Compensation (Schedule of Other Stock-Based Awards Activity) (Details) (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013
Time-Vested Restricted Share Units [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award	'
Nonvested at January 1, 2013	324
Granted	75
Vested	-117
Forfeited	-25
Nonvested at December 31, 2013	257
Nonvested at January 1, 2013, Weighted-Average Grant-Date Fair Value	$75.24
Granted, Weighted-Average Grant-Date Fair Value	$89.29
Vested, Weighted-Average Grant-Date Fair Value	$70.39
Forfeited, Weighted-Average Grant-Date Fair Value	$76.52
Nonvested at December 31, 2013, Weighted-Average Grant-Date Fair Value	$81.38
Performance-Based Restricted Share Units [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award	'
Nonvested at January 1, 2013	2,187
Granted	713
Vested	-294
Forfeited	-523
Nonvested at December 31, 2013	2,083
Nonvested at January 1, 2013, Weighted-Average Grant-Date Fair Value	$67.41
Granted, Weighted-Average Grant-Date Fair Value	$100.42
Vested, Weighted-Average Grant-Date Fair Value	$62.72
Forfeited, Weighted-Average Grant-Date Fair Value	$64.75
Nonvested at December 31, 2013, Weighted-Average Grant-Date Fair Value	$79.98

Employee_Postretirement_Benefi2

Employee Postretirement Benefits (Narrative) (Details) (USD $)

12 Months Ended

12 Months Ended

In Millions, unless otherwise specified

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Lump sum [Member]

Pension Plans, Defined Benefit [Member]

Pension Plans, Defined Benefit [Member]

Pension Plans, Defined Benefit [Member]

Pension Plans, Defined Benefit [Member]

Pension Plans, Defined Benefit [Member]

Minimum [Member]

Maximum [Member]

Equity Securities [Member]

Fixed Income Funds [Member]

UNITED STATES

UNITED STATES

Pension Plans, Defined Benefit [Member]

Pension Plans, Defined Benefit [Member]

Defined Benefit Plan, Target Plan Asset Allocations

'

'

'

'

'

'

'

'

'

'

'

30.00%

70.00%

Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year

'

6.20%

'

'

'

'

'

'

'

'

'

'

'

Defined Benefit Plan, Health Care Cost Trend Rate Assumed For Fifth Succeeding Fiscal Year

'

5.00%

'

'

'

'

'

'

'

'

'

'

'

Benefit payments

'

'

'

$116

($343)

($478)

'

'

'

'

'

'

'

Defined Benefit Plan, Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets, Aggregate Projected Benefit Obligation

'

'

'

'

6,164

6,590

'

3,866

4,375

'

'

'

'

Fair value of plan assets

'

'

'

'

5,567

5,375

5,214

3,565

3,553

'

'

'

'

Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate

6.16%

6.43%

6.68%

'

'

'

'

'

'

'

'

'

'

Defined Benefit Plan, Significant Concentrations of Risk

'

'there were no significant concentrations of equity or debt securities in any single issuer or industry.

'

'

'

'

'

'

'

'

'

'

'

Defined Benefit Plan, Estimated Future Employer Contributions in Next Fiscal Year

'

'

'

'

'

'

'

'

'

$100

$200

'

'

Employee_Postretirement_Benefi3

Employee Postretirement Benefits (Summarized Financial Information about Postretirement plans, Excluding Defined Contribution Retirement Plans) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Noncurrent liability—accrued benefit cost	($1,312)	($1,992)	'
Defined Benefit Pension [Member]	'	'	'
Benefit obligation at beginning of year	6,590	5,920	'
Service cost	53	45	57
Interest cost	257	279	307
Actuarial loss (gain)	-422	854	'
Currency and other	47	79	'
Benefit payments from plans	-343	-478	'
Direct benefit payments	-13	-14	'
Curtailment and settlements	-5	-95	'
Benefit obligation at end of year	6,164	6,590	5,920
Fair value of plan assets at beginning of year	5,375	5,214	'
Actual return on plan assets	268	556	'
Employer contributions	220	110	'
Currency and other	47	60	'
Benefit payments	-343	-478	'
Settlements	0	-87	'
Fair value of plan assets at end of year	5,567	5,375	5,214
Funded Status	-597	-1,215	'
Noncurrent asset—prepaid benefit cost	9	8	'
Current liability—accrued benefit cost	-12	-12	'
Noncurrent liability—accrued benefit cost	-594	-1,211	'
Net amount recognized	-597	-1,215	'
Other Postretirement Benefit Plans, Defined Benefit [Member]	'	'	'
Benefit obligation at beginning of year	824	788	'
Service cost	17	15	14
Interest cost	32	36	41
Actuarial loss (gain)	-60	37	'
Currency and other	0	3	'
Benefit payments from plans	0	0	'
Direct benefit payments	-52	-55	'
Curtailment and settlements	0	0	'
Benefit obligation at end of year	761	824	788
Fair value of plan assets at beginning of year	0	0	'
Actual return on plan assets	0	0	'
Employer contributions	0	0	'
Currency and other	0	0	'
Benefit payments	0	0	'
Settlements	0	0	'
Fair value of plan assets at end of year	0	0	0
Funded Status	-761	-824	'
Noncurrent asset—prepaid benefit cost	0	0	'
Current liability—accrued benefit cost	-56	-56	'
Noncurrent liability—accrued benefit cost	-705	-768	'
Net amount recognized	($761)	($824)	'

Employee_Postretirement_Benefi4

Employee Postretirement Benefits (Principal Plans and All Other Pension Plans) (Details) (Defined Benefit Pension [Member], USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
In Millions, unless otherwise specified
Projected benefit obligation (“PBO”)	$6,164	$6,590	'
Accumulated benefit obligation (“ABO”)	5,994	6,469	'
Fair value of plan assets	5,567	5,375	5,214
Principal Plans [Member]	'	'	'
Projected benefit obligation (“PBO”)	5,640	6,071	'
Accumulated benefit obligation (“ABO”)	5,555	6,049	'
Fair value of plan assets	5,205	5,063	'
All Other Pension Plans [Member]	'	'	'
Projected benefit obligation (“PBO”)	524	519	'
Accumulated benefit obligation (“ABO”)	439	420	'
Fair value of plan assets	362	312	'
UNITED STATES	'	'	'
Projected benefit obligation (“PBO”)	3,866	4,375	'
Fair value of plan assets	$3,565	$3,553	'

Employee_Postretirement_Benefi5

Employee Postretirement Benefits (Pension Plans with an ABO in Excess of Plan Assets) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Fair value of plan assets	$5,163	$5,335
ABO in Excess of Plan Assets [Member]	'	'
PBO	5,722	6,558
ABO	$5,622	$6,440

Employee_Postretirement_Benefi6

Employee Postretirement Benefits (Components of Net Periodic Benefit Cost) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Defined Benefit Pension [Member]	'		'		'
Service cost	$53		$45		$57
Interest cost	257		279		307
Expected return on plan assets(a)	-331	[1]	-329	[1]	-345	[1]
Recognized net actuarial loss	120		111		94
Curtailment and settlements	-31		20		0
Other	1		-4		6
Net periodic benefit cost	69		122		119
Other Postretirement Benefit Plans, Defined Benefit [Member]	'		'		'
Service cost	17		15		14
Interest cost	32		36		41
Expected return on plan assets(a)	0		0		0
Recognized net actuarial loss	3		1		0
Curtailment and settlements	0		0		0
Other	-2		-1		1
Net periodic benefit cost	$50		$51		$56
[1]	The expected return on plan assets is determined by multiplying the fair value of plan assets at the remeasurement date, typically the prior year-end, and adjusted for estimated current year cash benefit payments and contributions, by the expected long-term rate of return.

Employee_Postretirement_Benefi7

Employee Postretirement Benefits (Weighted-Average Assumptions) (Details)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Defined Benefit Pension [Member]	'	'	'
Net cost, Discount rate	4.04%	4.87%	5.51%
Net cost, Expected long-term return on plan assets	6.26%	6.49%	7.14%
Net cost, Rate of compensation increase	2.73%	2.91%	4.05%
Benefit obligations, Discount rate	4.66%	4.04%	'
Benefit obligations, Rate of compensation increase	2.67%	2.73%	'
Other Postretirement Benefit Plans, Defined Benefit [Member]	'	'	'
Net cost, Discount rate	3.97%	4.70%	5.44%
Net cost, Expected long-term return on plan assets	0.00%	0.00%	0.00%
Net cost, Rate of compensation increase	0.00%	0.00%	0.00%
Benefit obligations, Discount rate	4.97%	3.97%	'
Benefit obligations, Rate of compensation increase	0.00%	0.00%	'

Employee_Postretirement_Benefi8

Employee Postretirement Benefits (Pension Plan Assets of the Principal Plans Measured at fair value) (Details) (USD $)

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

In Millions, unless otherwise specified

Fair Value, Inputs, Level 3 [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Principal Plans [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 3 [Member]

Fair Value, Inputs, Level 3 [Member]

U.S. Equity [Member]

U.S. Equity [Member]

U.S. Equity [Member]

U.S. Equity [Member]

U.S. Equity [Member]

U.S. Equity [Member]

U.S. Equity [Member]

U.S. Equity [Member]

U.S. Equity [Member]

U.S. Equity [Member]

U.S. Equity [Member]

U.S. Equity [Member]

Non-U.S. Equity [Member]

Non-U.S. Equity [Member]

Non-U.S. Equity [Member]

Non-U.S. Equity [Member]

Non-U.S. Equity [Member]

Non-U.S. Equity [Member]

Non-U.S. Equity [Member]

Non-U.S. Equity [Member]

International Bonds [Member]

International Bonds [Member]

International Bonds [Member]

International Bonds [Member]

International Bonds [Member]

International Bonds [Member]

International Bonds [Member]

International Bonds [Member]

U.S. securitized fixed income [Member]

U.S. securitized fixed income [Member]

U.S. securitized fixed income [Member]

U.S. securitized fixed income [Member]

U.S. securitized fixed income [Member]

U.S. securitized fixed income [Member]

U.S. securitized fixed income [Member]

U.S. securitized fixed income [Member]

Cash and Cash Equivalents [Member]

Cash and Cash Equivalents [Member]

Cash and Cash Equivalents [Member]

Cash and Cash Equivalents [Member]

Cash and Cash Equivalents [Member]

Cash and Cash Equivalents [Member]

Cash and Cash Equivalents [Member]

Cash and Cash Equivalents [Member]

Cash and Cash Equivalents [Member]

Cash and Cash Equivalents [Member]

Cash and Cash Equivalents [Member]

Cash and Cash Equivalents [Member]

Cash and Cash Equivalents [Member]

Cash and Cash Equivalents [Member]

Cash and Cash Equivalents [Member]

Cash and Cash Equivalents [Member]

U.S. government and municipals [Member]

U.S. government and municipals [Member]

U.S. government and municipals [Member]

U.S. government and municipals [Member]

U.S. government and municipals [Member]

U.S. government and municipals [Member]

U.S. government and municipals [Member]

U.S. government and municipals [Member]

U.S. government and municipals [Member]

U.S. government and municipals [Member]

U.S. government and municipals [Member]

U.S. government and municipals [Member]

U.S. corporate debt [Member]

U.S. corporate debt [Member]

U.S. corporate debt [Member]

U.S. corporate debt [Member]

U.S. corporate debt [Member]

U.S. corporate debt [Member]

U.S. corporate debt [Member]

U.S. corporate debt [Member]

U.S. corporate debt [Member]

U.S. corporate debt [Member]

U.S. corporate debt [Member]

U.S. corporate debt [Member]

U.S. corporate debt [Member]

U.S. corporate debt [Member]

U.S. corporate debt [Member]

U.S. corporate debt [Member]

Multi-sector [Member]

Multi-sector [Member]

Multi-sector [Member]

Multi-sector [Member]

Multi-sector [Member]

Multi-sector [Member]

Multi-sector [Member]

Multi-sector [Member]

International Equity [Member]

International Equity [Member]

International Equity [Member]

International Equity [Member]

Global equity [Member]

Global equity [Member]

Global equity [Member]

Global equity [Member]

Global equity [Member]

Global equity [Member]

Global equity [Member]

Global equity [Member]

Insurance Contract [Member]

Insurance Contract [Member]

Insurance Contract [Member]

Insurance Contract [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 3 [Member]

Fair Value, Inputs, Level 3 [Member]

Fair Value, Inputs, Level 3 [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 3 [Member]

Fair Value, Inputs, Level 3 [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 3 [Member]

Fair Value, Inputs, Level 3 [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 3 [Member]

Fair Value, Inputs, Level 3 [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 3 [Member]

Fair Value, Inputs, Level 3 [Member]

Fair Value, Inputs, Level 3 [Member]

Fair Value, Inputs, Level 3 [Member]

Mutual and Pooled Funds [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 3 [Member]

Fair Value, Inputs, Level 3 [Member]

Fair Value, Inputs, Level 3 [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 3 [Member]

Fair Value, Inputs, Level 3 [Member]

Fair Value, Inputs, Level 3 [Member]

Fair Value, Inputs, Level 3 [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 3 [Member]

Fair Value, Inputs, Level 3 [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 3 [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 3 [Member]

Fair Value, Inputs, Level 3 [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 3 [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Mutual and Pooled Funds [Member]

Fair value of plan assets

$1

$5,205

$5,063

$146

$203

$5,029

$4,860

$30

$0

$1

$4

$678

$1

$4

$3

$0

$0

$675

$0

$0

$0

$123

$925

$1

$1

$122

$924

$0

$0

$1,089

$920

$0

$0

$1,089

$920

$0

$0

$8

$3

$0

$0

$8

$3

$0

$0

$33

$23

$173

$143

$33

$23

$34

$0

$0

$0

$139

$143

$0

$0

$0

$0

$211

$132

$490

$71

$31

$0

$140

$101

$490

$0

$0

$0

$1,654

$1,112

$186

$199

$0

$0

$0

$0

$1,654

$1,112

$186

$199

$0

$0

$0

$0

$2

$2

$2

$2

$0

$0

$0

$0

$143

$143

$0

$0

$1,691

$293

$0

$0

$1,691

$293

$0

$0

$30

$0

$0

$30

Employee_Postretirement_Benefi9

Employee Postretirement Benefits (Cash Contributions to its Pension Trusts) (Details) (USD $)	Dec. 31, 2013
In Millions, unless otherwise specified
Defined Benefit Pension [Member]	'
Defined Benefit Plan, Expected Future Benefit Payments in Year One	$369
Defined Benefit Plan, Expected Future Benefit Payments in Year Two	374
Defined Benefit Plan, Expected Future Benefit Payments in Year Three	374
Defined Benefit Plan, Expected Future Benefit Payments in Year Four	382
Defined Benefit Plan, Expected Future Benefit Payments in Year Five	386
Defined Benefit Plan, Expected Future Benefit Payments in Five Fiscal Years Thereafter	2,005
Other Postretirement Benefit Plans, Defined Benefit [Member]	'
Defined Benefit Plan, Expected Future Benefit Payments in Year One	57
Defined Benefit Plan, Expected Future Benefit Payments in Year Two	59
Defined Benefit Plan, Expected Future Benefit Payments in Year Three	60
Defined Benefit Plan, Expected Future Benefit Payments in Year Four	61
Defined Benefit Plan, Expected Future Benefit Payments in Year Five	63
Defined Benefit Plan, Expected Future Benefit Payments in Five Fiscal Years Thereafter	$326

Recovered_Sheet1

Employee Postretirement Benefits (Defined Contribution Pension Plans) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Costs charged to expense for defined contribution pension plans	$117	$108	$113
UNITED STATES	'	'	'
Costs charged to expense for defined contribution pension plans	90	82	77
Outside the United States [Member]	'	'	'
Costs charged to expense for defined contribution pension plans	$27	$26	$36

Accumulated_Other_Comprehensiv2

Accumulated Other Comprehensive Income (Narratives) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013
Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), after Tax [Abstract]	'
Defined Benefit Plan, Accumulated Other Comprehensive Income Net Gains (Losses), after Tax	$1,717
Defined Benefit Plan, Accumulated Other Comprehensive Income Net Prior Service Cost Credit, after Tax	35
Pension and Other Postretirement Benefit Plans, Amounts that Will be Amortized from Accumulated Other Comprehensive Income (Loss) in Next Fiscal Year [Abstract]	'
Defined Benefit Plan, Amortization of Net Gains (Losses)	98
Defined Benefit Plan, Amortization of Net Prior Service Cost (Credit)	$3

Accumulated_Other_Comprehensiv3

Accumulated Other Comprehensive Income (Change in Components of Accumulated Other Comprehensive Income Attributable to Kimberly-Clark (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Unrealized Translation - Beginning balance	($26)	($221)	'
Cash flow hedge and other - Beginning balance	-52	-36	'
Other comprehensive income/(loss) before reclassifications	-499	195	'
(Income)/loss reclassified from AOCI	0	0	'
Other comprehensive income/(loss) before reclassifications	24	-13	'
Income/loss reclassified from AOCI	-6	-3	'
Unrealized currency translation adjustments	-494	215	-249
Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax	-302	377	134
Unrealized Translation - Ending balance	-525	-26	-221
Cash flow hedge and other - Ending balance	-34	-52	-36
Other	17	-16	-30
Parent [Member]	'	'	'
Unrealized currency translation adjustments	-499	195	-236
Other	18	-16	'
Defined Benefit Pension [Member]	'	'	'
Defined benefit and other postretirement benefit plans - Beginning balance	1,928	1,578	'
Other comprehensive income/(loss) before reclassifications	218	-407	'
(Income)/loss reclassified from AOCI	42	57	'
Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax	260	-350	-132
Defined benefit and other postretirement benefit plans - Ending balance	1,668	1,928	1,578
Defined Benefit Pension [Member] | Parent [Member]	'	'	'
Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax	-260	350	'
Other Postretirement Benefit Plans, Defined Benefit [Member]	'	'	'
Defined benefit and other postretirement benefit plans - Beginning balance	53	31	'
Other comprehensive income/(loss) before reclassifications	36	-20	'
(Income)/loss reclassified from AOCI	2	-2	'
Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax	38	-22	-1
Defined benefit and other postretirement benefit plans - Ending balance	15	53	31
Other Postretirement Benefit Plans, Defined Benefit [Member] | Parent [Member]	'	'	'
Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax	($38)	$22	'

Accumulated_Other_Comprehensiv4

Accumulated Other Comprehensive Income (Components of Stockholders' Equity) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Unrealized translation	($495)	$204	($243)
Tax effect	-4	-9	7
Unrealized currency translation adjustments	-494	215	-249
Employee postretirement benefits	-302	377	134
Recognition of effective portion of hedges	37	-20	-81
Amortization included in net income	-10	0	39
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax	31	-21	-55
Tax effect	-13	5	24
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax	18	-16	-31
Change in AOCI	-183	-193	-400
Pension Plans, Defined Benefit [Member]	'	'	'
Tax effect	-176	165	99
Employee postretirement benefits	260	-350	-132
Other Postretirement Benefit Plans, Defined Benefit [Member]	'	'	'
Tax effect	-24	12	-2
Employee postretirement benefits	38	-22	-1
Parent [Member]	'	'	'
Unrealized currency translation adjustments	-499	195	-236
Parent [Member] | Pension Plans, Defined Benefit [Member]	'	'	'
Employee postretirement benefits	-260	350	'
Parent [Member] | Other Postretirement Benefit Plans, Defined Benefit [Member]	'	'	'
Employee postretirement benefits	-38	22	'
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]	'	'	'
Currency and other	4	-1	-13
Unrecognized net actuarial loss and transition amount [Member] | Pension Plans, Defined Benefit [Member]	'	'	'
Funded status recognition	356	-588	-396
Amortization included in net periodic benefit cost	120	90	94
Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, before Tax	468	-518	-304
Unrecognized net actuarial loss and transition amount [Member] | Other Postretirement Benefit Plans, Defined Benefit [Member]	'	'	'
Funded status recognition	62	-31	-31
Amortization included in net periodic benefit cost	3	-1	0
Currency and other	-8	-20	-2
Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, before Tax	65	-32	-31
Unrecognized prior service cost [Member] | Pension Plans, Defined Benefit [Member]	'	'	'
Currency and other	-1	3	-4
Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, before Tax	-32	3	73
Funded status recognition	0	0	74
Amortization included in net periodic benefit cost	-31	0	3
Unrecognized prior service cost [Member] | Other Postretirement Benefit Plans, Defined Benefit [Member]	'	'	'
Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, before Tax	-3	-2	32
Funded status recognition	-3	0	31
Amortization included in net periodic benefit cost	$0	($2)	$1

Leases_and_Commitments_Narrati

Leases and Commitments (Narrative) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Leases and Commitments	'	'	'
Consolidated rental expense	$333	$283	$278
2014	481	'	'
2015	259	'	'
2016	189	'	'
2017	173	'	'
2018	177	'	'
Beyond 2018	$334	'	'

Leases_and_Commitments_Future_

Leases and Commitments (Future Minimum Obligations under Operating Leases) (Details) (USD $)	Dec. 31, 2013
In Millions, unless otherwise specified
Leases and Commitments [Line Items]	'
2014	$189
2015	155
2016	124
2017	113
2018	76
Thereafter	107
Future minimum obligations	$764

Objectives_and_Strategies_for_2

Objectives and Strategies for Using Derivatives (Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Notional Amount of Interest Rate Fair Value Hedge Derivatives	$250,000,000	'	'
Fair value hedge ineffectiveness is immaterial assertion	'Fair value hedges resulted in no significant ineffectiveness in each of the three years ended December 31, 2013	'	'
Gain from hedged firm commitment not qualifying as fair value hedge	0	'	'
Notional Amount of Foreign Currency Cash Flow Hedge Derivatives	1,000,000,000	'	'
Notional Amount of Interest Rate Cash Flow Hedge Derivatives	200,000,000	'	'
Cash flow hedge ineffectiveness is immaterial assertion	'Cash flow hedges resulted in no significant ineffectiveness in each of the three years ended December 31, 2013	'	'
Gain (Loss) on Discontinuation of Cash Flow Hedge Due to Forecasted Transaction Probable of Not Occurring, Net	0	'	'
Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments	75,000,000	67,000,000	3,000,000
Notional Amount of Foreign Currency Derivative Instruments Not Designated as Hedging Instruments	$2,000,000,000	'	'
Cash Flow Hedging [Member]	'	'	'
Derivative, Maturity Date	1-Jan-16	'	'

Objectives_and_Strategies_for_3

Objectives and Strategies for Using Derivatives (Classified by Risk) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Assets	$62	$61
Liabilities	49	63
Foreign Exchange Contract [Member]	'	'
Assets	34	52
Liabilities	49	17
Interest Rate Contract [Member]	'	'
Assets	22	7
Liabilities	0	43
Commodity Contract [Member]	'	'
Assets	6	2
Liabilities	$0	$3

Income_Taxes_Narrative_Details

Income Taxes (Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Valuation Allowance	'	'
Income tax loss carryforwards	$1,000,000,000	'
Income tax loss carryforwards expire amount	368,000,000	'
Income tax loss carryforwards expiration dates	'2014 through 2031	'
Remaining amount of loss carryforwards that has no expiration date	654,000,000	'
Unremitted earnings	9,800,000,000	'
Unrecognized tax benefits	309,000,000	'
Total accrued penalties and net accrued interest	42,000,000	47,000,000
Aggregate resolution of uncertainties	$180,000,000	'
Year federal income tax returns have been audited	'2009	'
Administrative appeals or litigation	'1999 to 2009	'
Pending refund actions, period	'two	'
State and Local Jurisdiction [Member]	'	'
Valuation Allowance	'	'
Statute for potential adjustments, period	'3 to 5 years	'

Income_Taxes_Analysis_of_the_P

Income Taxes (Analysis of the Provision for Income Taxes) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Tax Expense (Benefit) [Abstract]	'	'	'
United States	$350	$182	$43
State	110	30	32
Other countries	318	332	311
Total	778	544	386
United States	85	204	254
State	14	34	29
Other countries	52	-14	-9
Total	151	224	274
Total provision for income taxes	$929	$768	$660

Income_Taxes_Income_before_Inc

Income Taxes (Income before Income Taxes) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Tax Expense (Benefit) [Abstract]	'	'	'
United States	$1,764	$1,415	$1,317
Other countries	1,181	1,005	866
Income Before Income Taxes and Equity Interests	$2,945	$2,420	$2,183

Income_Taxes_Deferred_Income_T

Income Taxes (Deferred Income Tax Assets (Liabilities)) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Income Tax Expense (Benefit) [Abstract]	'	'
Pension and other postretirement benefits	$728	$972
Tax credits and loss carryforwards	604	729
Deferred Tax Assets, Property, Plant and Equipment	104	110
Other	516	492
Deferred Tax Assets, Gross	1,952	2,303
Deferred Tax Assets, Valuation Allowance	-197	-215
Deferred Tax Assets, Net	1,755	2,088
Deferred Tax Liability Noncurrent Pension Postretirement And Other Employee Benefits	-259	-269
Deferred Tax Liabilities, Property, Plant and Equipment	-1,244	-1,228
Installment sales	-6	-120
Deferred Tax Liabilities, Undistributed Foreign Earnings	-205	-108
Deferred Tax Liabilities, Other	-390	-385
Deferred Tax Liabilities, Gross	-2,104	-2,110
Deferred Tax Liabilities, Net	($349)	($22)

Income_Taxes_Reconciliation_of

Income Taxes (Reconciliation of Income Tax Provision) (Details)	12 Months Ended
	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Income Tax Expense (Benefit) [Abstract]	'		'		'
Tax at U.S. statutory rate applied to income before income taxes	35.00%		35.00%		35.00%
State income taxes, net of federal tax benefit	2.70%		1.70%		1.80%
Statutory rates other than U.S. statutory rate	-2.90%		-2.80%		-2.30%
Other-net	-3.30%	[1]	-2.20%	[1]	-4.30%	[1]
Effective income tax rate	31.50%		31.70%		30.20%
[1]	Other - net is comprised of numerous items, none of which is greater than 1.75 percent of income before income taxes.

Income_Taxes_Unrecognized_Inco

Income Taxes (Unrecognized Income Tax Benefits) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Tax Expense (Benefit) [Abstract]	'	'	'
Balance at January 1	$435	$558	$568
Gross increases for tax positions of prior years	73	30	17
Gross decreases for tax positions of prior years	-31	-104	-60
Gross increases for tax positions of the current year	37	52	55
Settlements	-35	-100	-15
Unrecognized Tax Benefits, Other	6	1	7
Balance at December 31	$473	$435	$558

Income_Taxes_Remaining_Tax_Yea

Income Taxes (Remaining Tax Years Subject to Examination) (Details)	12 Months Ended
	Dec. 31, 2012
Minimum [Member] | United States	'
Income Tax Examination [Line Items]	'
Tax years subject to examination	'2010
Minimum [Member] | United Kingdom	'
Income Tax Examination [Line Items]	'
Tax years subject to examination	'2011
Minimum [Member] | Canada	'
Income Tax Examination [Line Items]	'
Tax years subject to examination	'2008
Minimum [Member] | Korea	'
Income Tax Examination [Line Items]	'
Tax years subject to examination	'2007
Minimum [Member] | Australia	'
Income Tax Examination [Line Items]	'
Tax years subject to examination	'2008
Maximum [Member] | United States	'
Income Tax Examination [Line Items]	'
Tax years subject to examination	'2013
Maximum [Member] | United Kingdom	'
Income Tax Examination [Line Items]	'
Tax years subject to examination	'2013
Maximum [Member] | Canada	'
Income Tax Examination [Line Items]	'
Tax years subject to examination	'2013
Maximum [Member] | Korea	'
Income Tax Examination [Line Items]	'
Tax years subject to examination	'2013
Maximum [Member] | Australia	'
Income Tax Examination [Line Items]	'
Tax years subject to examination	'2013

Earnings_Per_Share_Narratives_

Earnings Per Share (Narratives) (Details)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
In Millions, unless otherwise specified
Earnings Per Share [Abstract]	'	'	'
Common shares outstanding	380.8	389.3	395.7

Earnings_Per_Share_Average_Com

Earnings Per Share (Average Common shares Outstanding Basic and Diluted) (Details)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Earnings Per Share [Abstract]	'	'	'
Average shares outstanding	384	393	395.4
Participating securities	0	0	0.3
Basic	384	393	395.7
Dilutive effect of restricted share and restricted share unit awards	3.3	3.1	2.9
Diluted	387.3	396.1	398.6

Earnings_Per_Share_Options_Out

Earnings Per Share (Options Outstanding not Included in Computation of Diluted EPS) (Details) (USD $)	12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Average number of share equivalents (millions)	1.1	1.1	3.6
Weighted-average exercise price	$103.29	$78.54	$71.49
Options outstanding at year-end (millions)	1.8	1.7	3

Business_Segment_and_Geographi1

Business Segment and Geographic Data Information (Narrative) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Net sales to Wal-Mart Stores percent	12.00%	12.00%	12.00%
Income Tax Reconciliation, Nondeductible Expense	'	'	$32
K-C Venezuela [Member]	'	'	'
Charge for Devaluation Under Highly Inflationary Accounting	36	'	'

Business_Segment_and_Geographi2

Business Segment and Geographic Data Information (Information Concerning Consolidated Operations by Business Segment) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Net Sales	$21,152	[1]	$21,063	[1]	$20,846	[1]
Operating Profit	3,208		2,686		2,442
Depreciation and Amortization	863		857		1,091
Assets	18,919		19,873		19,373
Charges for workforce reductions and other exit costs	'		434		'
Capital Spending	953		1,093		968
United States	'		'		'
Net Sales	9,783		9,720		9,715
Personal Care [Member]	'		'		'
Net Sales	9,536		9,576		9,128
Operating Profit	1,698	[2]	1,660	[2]	1,526	[2]
Depreciation and Amortization	332		315		296
Assets	6,623		7,014		6,582
Charges for workforce reductions and other exit costs	'		213		'
Capital Spending	461		551		543
Consumer Tissue [Member]	'		'		'
Net Sales	6,637		6,527		6,770
Operating Profit	988	[2]	887	[2]	775	[2]
Depreciation and Amortization	318		331		541
Assets	5,483		5,531		5,685
Charges for workforce reductions and other exit costs	'		191		'
Capital Spending	328		352		255
K-C Professional and Other [Member]	'		'		'
Net Sales	3,323		3,283		3,294
Operating Profit	608	[2]	545	[2]	487	[2]
Depreciation and Amortization	138		141		187
Assets	2,431		2,739		2,783
Charges for workforce reductions and other exit costs	'		29		'
Capital Spending	118		116		114
Health Care [Member]	'		'		'
Net Sales	1,618		1,622		1,606
Operating Profit	230	[2]	229	[2]	219	[2]
Depreciation and Amortization	71		59		55
Assets	2,370		2,531		2,529
Capital Spending	44		42		53
Corporate and Other [Member]	'		'		'
Net Sales	38		55		48
Operating Profit	-316	[2],[3]	-635	[2],[3]	-565	[2],[3]
Depreciation and Amortization	4		11		12
Assets	2,012		2,058		1,794
Capital Spending	2		32		3
Other (Income) And Expense, Net [Member]	'		'		'
Charges for workforce reductions and other exit costs	'		1		'
European Strategic Changes [Member]	'		'		'
Charges for workforce reductions and other exit costs	81		299		'
European Strategic Changes [Member] | Personal Care [Member]	'		'		'
Charges for workforce reductions and other exit costs	36		213		'
European Strategic Changes [Member] | Consumer Tissue [Member]	'		'		'
Charges for workforce reductions and other exit costs	27		66		'
European Strategic Changes [Member] | K-C Professional and Other [Member]	'		'		'
Charges for workforce reductions and other exit costs	13		20		'
European Strategic Changes [Member] | Other (Income) And Expense, Net [Member]	'		'		'
Charges for workforce reductions and other exit costs	5		0		'
Pulp And Tissue Restructuring [Member]	'		'		'
Charges for workforce reductions and other exit costs	'		135		415
Pulp And Tissue Restructuring [Member] | Personal Care [Member]	'		'		'
Charges for workforce reductions and other exit costs	'		0		0
Pulp And Tissue Restructuring [Member] | Consumer Tissue [Member]	'		'		'
Charges for workforce reductions and other exit costs	'		125		357
Pulp And Tissue Restructuring [Member] | K-C Professional and Other [Member]	'		'		'
Charges for workforce reductions and other exit costs	'		9		56
Pulp And Tissue Restructuring [Member] | Other (Income) And Expense, Net [Member]	'		'		'
Charges for workforce reductions and other exit costs	'		$1		$2
[1]	Net sales in the United States to third parties totaled $9,783, $9,720 and $9,715 in 2013, 2012 and 2011, respectively.
[2]	Segment operating profit excludes other (income) and expense, net and income and expenses not associated with the business segments.
[3]	Corporate & Other includes the following charges:

Business_Segment_and_Geographi3

Business Segment and Geographic Data Information (Sales of Principal Products) (Details) (USD $)	12 Months Ended
In Billions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Sales of Principal Products	$21.20	$21.10	$20.80
Consumer Tissue Products [Member]	'	'	'
Sales of Principal Products	6.6	6.5	6.7
Diapers [Member]	'	'	'
Sales of Principal Products	7	7.1	6.8
Away from Home Professional Products [Member]	'	'	'
Sales of Principal Products	3.3	3.3	3.3
All Other [Member]	'	'	'
Sales of Principal Products	$4.30	$4.20	$4

Supplemental_Data_Supplemental

Supplemental Data Supplemental Data (Narrative) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Equity Method Investment, Ownership Percentage	20.00%	'
Investments in Equity Companies	$382,000,000	$355,000,000
Retained Earnings, Undistributed Earnings from Equity Method Investees	1,100,000,000	'
Property, Plant and Equipment, Net	7,948,000,000	8,095,000,000
United States	'	'
Property, Plant and Equipment, Net	3,917,000,000	4,040,000,000
Kimberly-Clark Lever Private Limited (India) [Member]	'	'
Equity Method Investment, Ownership Percentage	50.00%	'
Kimberly-Clark de Mexico, S.A.B. de C.V. and subsidiaries [Member]	'	'
Equity Method Investment, Ownership Percentage	47.90%	'
Investments in Equity Companies	269,000,000	'
Equity Method Investments, Fair Value Disclosure	$4,300,000,000	'
Olayan Kimberly-Clark Arabia [Member]	'	'
Equity Method Investment, Ownership Percentage	49.00%	'
Olayan Kimberly-Clark (Bahrain) WLL [Member]	'	'
Equity Method Investment, Ownership Percentage	49.00%	'
Tecnosur S.A. (Colombia) [Member]	'	'
Equity Method Investment, Ownership Percentage	50.00%	'

Supplemental_Data_Supplemental1

Supplemental Data (Supplemental Income Statement Data) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Supplemental Data	'	'	'
Advertising expense	$777	$810	$686
Research expense	$360	$356	$316

Supplemental_Data_Supplemental2

Supplemental Data Supplemental Data (Equity Method Investment Data) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Net Sales	$2,638	$2,514	$2,446
Gross Profit	950	864	796
Operating Profit	642	567	514
Net Income	426	368	335
Corporation's Share of Net Income	205	176	161
Current Assets	1,197	1,054	1,000
Non- Current Assets	1,124	1,068	906
Current Liabilities	847	712	491
Non- Current Liabilities	845	837	872
Stockholders' Equity	$629	$573	$543

Supplemental_Data_Supplemental3

Supplemental Data Supplemental Data (Summary of Accounts Receivable, Net) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Supplemental Data (Millions of dollars) [Abstract]	'	'
From Customers	$2,345	$2,346
Other	271	376
Less allowance for doubtful accounts and sales discounts	-71	-80
Total	$2,545	$2,642

Supplemental_Data_Summary_of_I

Supplemental Data (Summary of Inventories) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Raw materials	$462	$494
Work in process	286	329
Finished goods	1,401	1,442
Supplies and other	326	314
Gross inventories	2,475	2,579
Excess of FIFO or weighted-average cost over LIFO cost	-242	-231
Total	2,233	2,348
LIFO	'	'
Raw materials	143	148
Work in process	189	194
Finished goods	648	656
Supplies and other	0	0
Gross inventories	980	998
Excess of FIFO or weighted-average cost over LIFO cost	-242	-231
Total	738	767
Non- LIFO	'	'
Raw materials	319	346
Work in process	97	135
Finished goods	753	786
Supplies and other	326	314
Gross inventories	1,495	1,581
Excess of FIFO or weighted-average cost over LIFO cost	0	0
Total	$1,495	$1,581

Supplemental_Data_Supplemental4

Supplemental Data Supplemental Data (Summary of Property, Plant and Equipment, Net) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Supplemental Data	'	'
Land	$196	$199
Buildings	2,776	2,732
Machinery and Equipment	14,193	13,993
Construction in Progress	515	732
Total before accumulated depreciation	17,680	17,656
Less accumulated depreciation	-9,732	-9,561
Total	$7,948	$8,095

Supplemental_Data_Summary_of_A

Supplemental Data (Summary of Accrued Expenses) (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Supplemental Data	'	'
Accrued advertising and promotion	$355	$372
Accrued salaries and wages	471	456
Accrued rebates	358	340
Accrued taxes - income and other	336	336
Other	540	740
Total	$2,060	$2,244

Supplemental_Data_Supplemental5

Supplemental Data Supplemental Data (Summary of Cash Flow Effects of Decrease (Increase) in Operating Working Capital) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Accounts Receivable	$4	($38)	($169)
Inventories	100	9	9
Prepaid Expenses	7	1	-19
Trade Accounts Payable	128	45	161
Accrued Expenses	-177	133	-91
Accrued Income Taxes	-90	13	-107
Derivatives	5	-86	33
Currency	-135	42	-79
Decrease (increase) in operating working capital	($158)	$119	($262)

Supplemental_Data_Other_Cash_F

Supplemental Data (Other Cash Flow Data and Interest Expense) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Supplemental Data	'	'	'
Interest paid	$307	$299	$273
Income Taxes Paid	$776	$451	$463

Valuation_and_Qualifying_Accou2

Valuation and Qualifying Accounts (Schedule of Valuation and Qualifying Accounts) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2010		Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011		Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2010
	Allowance for Doubtful Accounts [Member]		Allowance for Doubtful Accounts [Member]		Allowance for Doubtful Accounts [Member]		Deferred Taxes [Member]		Deferred Taxes [Member]		Deferred Taxes [Member]		Allowances for Sales Discounts [Member]		Allowances for Sales Discounts [Member]		Allowances for Sales Discounts [Member]
Balance at Beginning of Period	$60		$57		'		$215		$229		$287		$20		$21		'
Charged to Costs and Expenses	0		9		5		-11		-18		-51		275		280		275
Charged to Other Accounts	-4	[1]	0	[1]	-5	[1]	0		0		0		-1	[1]	0	[1]	0	[1]
Deductions	5	[2]	6	[2]	5	[2]	7	[3]	-4	[3]	7	[3]	274	[4]	281	[4]	272	[4]
Balance at End of Period	$51		$60		$62		$197		$215		$229		$20		$20		$18
[1]	Includes bad debt recoveries and the effects of changes in foreign currency exchange rates.
[2]	Primarily uncollectible receivables written off.
[3]	Represents the net currency effects of translating valuation allowances at current rates of exchange.
[4]	Sales discounts allowed.